Publications

Publications published since 2000 from OUS - Department of Infectious Diseases

494 publications found

Publications 2019

  1. Aberra H, Desalegn H, Berhe N, Mekasha B, Medhin G, Gundersen SG, Johannessen A (2019)
    The WHO guidelines for chronic hepatitis B fail to detect half of the patients in need of treatment in Ethiopia
    J Hepatol, 70 (6), 1065-1071
    DOI 10.1016/j.jhep.2019.01.037, PubMed 30929749
  2. Arnesen TM, Brantsæter AB, Nøkleby H (2019)
    Bacille Calmette-Guérin vaccination of healthcare personnel: changing epidemiology calls for new recommendations in Norway
    Eur Respir J, 53 (1)
    DOI 10.1183/13993003.01123-2018, PubMed 30630851
  3. Desalegn H, Aberra H, Berhe N, Medhin G, Mekasha B, Gundersen SG, Johannessen A (2019)
    Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study
    BMC Gastroenterol, 19 (1), 74
    DOI 10.1186/s12876-019-0993-1, PubMed 31092203
  4. Dukic AR, Gerbaud P, Guibourdenche J, Thiede B, Taskén K, Pidoux G (2019)
    Correction: Ezrin-anchored PKA phosphorylates serine 369 and 373 on connexin 43 to enhance gap junction assembly, communication, and cell fusion
    Biochem J, 476 (13), 1927
    DOI 10.1042/BCJ-2017-0529_COR, PubMed 31266855
  5. Hoel IM, Jørstad MD, Marijani M, Ruhwald M, Mustafa T, Dyrhol-Riise AM (2019)
    IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting
    Sci Rep, 9 (1), 3871
    DOI 10.1038/s41598-019-40458-0, PubMed 30846768
  6. Hotez PJ, Harrison W, Fenwick A, Bustinduy AL, Ducker C, Sabina Mbabazi P, Engels D, Floerecke Kjetland E (2019)
    Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women
    PLoS Negl Trop Dis, 13 (4), e0007025
    DOI 10.1371/journal.pntd.0007025, PubMed 30946746
  7. Huik K, Soodla P, Pauskar M, Owen SM, Luo W, Murphy G, Jogeda EL, Kallas E, Rajasaar H, Avi R, Masciotra S, Lutsar I, Del Amo J, Meyer L, Bucher HC, Chene G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Cartier A et al. (2019)
    The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx
    PLoS One, 14 (5), e0217048
  8. Johannessen A, Aberra H, Desalegn H, Gordien E, Berhe N (2019)
    A novel score to select patients for treatment in chronic hepatitis B: Results from a large Ethiopian cohort
    J Hepatol (in press)
    DOI 10.1016/j.jhep.2019.04.006, PubMed 31383377
  9. Jørstad MD, Dyrhol-Riise AM, Aßmus J, Marijani M, Sviland L, Mustafa T (2019)
    Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting
    BMC Infect Dis, 19 (1), 426
    DOI 10.1186/s12879-019-4034-z, PubMed 31096926
  10. Mortensen R, Clemmensen HS, Woodworth JS, Therkelsen ML, Mustafa T, Tonby K, Jenum S, Agger EM, Dyrhol-Riise AM, Andersen P (2019)
    Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice
    Commun Biol, 2, 288
    DOI 10.1038/s42003-019-0530-3, PubMed 31396568
  11. Nymoen Aasbrenn M, Skeie I, Berild D (2019)
    Compliance to antibiotic guidelines leads to more appropriate use of antibiotics in skin and soft tissue infections in injecting drug users
    Infect Dis (Lond), 51 (8), 570-577
    DOI 10.1080/23744235.2019.1617435, PubMed 31144548
  12. Orlien SMS, Berhe NB, Morgan MY, Johannessen A (2019)
    Khat-related liver disease in sub-Saharan Africa: neglected, yet important
    Lancet Glob Health, 7 (3), e310
    DOI 10.1016/S2214-109X(18)30527-8, PubMed 30784630
  13. Quist-Paulsen E, Kran AB, Lindland ES, Ellefsen K, Sandvik L, Dunlop O, Ormaasen V (2019)
    To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
    BMC Infect Dis, 19 (1), 80
    DOI 10.1186/s12879-018-3570-2, PubMed 30669985
  14. Roaldsnes E, Eikeland R, Berild D (2019)
    Lyme disease and antibiotic treatment
    Tidsskr. Nor. Laegeforen., 139 (7), 586
  15. Schwartz T, Jensenius M, Blomberg B, Fladeby C, Mæland A, Pettersen FO (2019)
    Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients
    Trop Dis Travel Med Vaccines, 5, 16
    DOI 10.1186/s40794-019-0092-x, PubMed 31463070
  16. Steens A, Winje BA, White RA, Odsbu I, Brantsæter AB, Vestrheim DF (2019)
    Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study
    Clin Infect Dis, 68 (8), 1367-1373
    DOI 10.1093/cid/ciy714, PubMed 30957160
  17. Stiksrud B, Aass HCD, Lorvik KB, Ueland T, Trøseid M, Dyrhol-Riise AM (2019)
    Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery
    AIDS, 33 (7), 1117-1129
    DOI 10.1097/QAD.0000000000002173, PubMed 30789356
  18. Storm-Larsen C, Stiksrud B, Eriksen C, Nowak P, Holm K, Thalme A, Dyrhol-Riise AM, Brix S, Hov JR, Trøseid M (2019)
    Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals
    AIDS, 33 (4), 645-653
    DOI 10.1097/QAD.0000000000002087, PubMed 30531315
  19. Thaulow CM, Berild D, Eriksen BH, Myklebust TÅ, Blix HS (2019)
    Potential for More Rational Use of Antibiotics in Hospitalized Children in a Country With Low Resistance: Data From eight Point Prevalence Surveys
    Pediatr Infect Dis J, 38 (4), 384-389
    DOI 10.1097/INF.0000000000002106, PubMed 30882728
  20. Tonby K, Mortensen R, Ruhwald M, Dyrhol-Riise AM, Jenum S (2019)
    KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment
    J Infect Dis, 220 (1), 174-176
    DOI 10.1093/infdis/jiz056, PubMed 30888024
  21. Waehre T, Petterson FO (2019)
    HIV medicines on offer gives worse treatment options
    Tidsskr. Nor. Laegeforen., 139 (2), 121-122
  22. Wolde M, Berhe N, Medhin G, Chala F, van Die I, Tsegaye A (2019)
    Inverse Associations of Schistosoma mansoni Infection and Metabolic Syndromes in Humans: A Cross-Sectional Study in Northeast Ethiopia
    Microbiol Insights, 12, 1178636119849934
    DOI 10.1177/1178636119849934, PubMed 31205419

Publications 2018

  1. Al-Shudifat AE, Azab M, Johannessen A, Al-Shdaifat A, Agraib LM, Tayyem RF (2018)
    Elevated fasting blood glucose, but not obesity, is associated with coronary artery disease in patients undergoing elective coronary angiography in a referral hospital in Jordan
    Ann Saudi Med, 38 (2), 111-117
    DOI 10.5144/0256-4947.2018.111, PubMed 29620544
  2. Azab M, Al-Shudifat AE, Johannessen A, Al-Shdaifat A, Agraib LM, Tayyem RF (2018)
    Are Risk Factors for Coronary Artery Disease Different in Persons With and Without Obesity?
    Metab Syndr Relat Disord, 16 (8), 440-445
    DOI 10.1089/met.2017.0152, PubMed 30088947
  3. Berild AG, Erichsen D, Berild D (2018)
    Treatment of community-acquired pneumonia
    Tidsskr Nor Laegeforen, 138 (19)
    DOI 10.4045/tidsskr.17.1115, PubMed 30497244
  4. Christensen EE, Taylor M, Zulu SG, Lillebo K, Gundersen SG, Holmen S, Kleppa E, Vennervald BJ, Ndhlovu PD, Kjetland EF (2018)
    Seasonal variations in Schistosoma haematobium egg excretion in school-age girls in rural KwaZulu-Natal Province, South Africa
    S Afr Med J, 108 (4), 352-355
    DOI 10.7196/SAMJ.2017.v108i4.12775, PubMed 29629689
  5. Desalegn H, Aberra H, Berhe N, Mekasha B, Stene-Johansen K, Krarup H, Pereira AP, Gundersen SG, Johannessen A (2018)
    Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia
    BMC Med, 16 (1), 234
    DOI 10.1186/s12916-018-1229-x, PubMed 30554571
  6. Eliassen KE, Reiso H, Berild D, Lindbæk M (2018)
    Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up
    Clin Microbiol Infect, 24 (12), 1290-1296
    DOI 10.1016/j.cmi.2018.02.028, PubMed 29505880
  7. Galappaththi-Arachchige HN, Holmen S, Koukounari A, Kleppa E, Pillay P, Sebitloane M, Ndhlovu P, van Lieshout L, Vennervald BJ, Gundersen SG, Taylor M, Kjetland EF (2018)
    Evaluating diagnostic indicators of urogenital Schistosoma haematobium infection in young women: A cross sectional study in rural South Africa
    PLoS One, 13 (2), e0191459
    DOI 10.1371/journal.pone.0191459, PubMed 29451887
  8. Galappaththi-Arachchige HN, Zulu SG, Kleppa E, Lillebo K, Qvigstad E, Ndhlovu P, Vennervald BJ, Gundersen SG, Kjetland EF, Taylor M (2018)
    Reproductive health problems in rural South African young women: risk behaviour and risk factors
    Reprod Health, 15 (1), 138
    DOI 10.1186/s12978-018-0581-9, PubMed 30111335
  9. Gautret P, Angelo KM, Asgeirsson H, Lalloo DG, Shaw M, Schwartz E, Libman M, Kain KC, Piyaphanee W, Murphy H, Leder K, Vincelette J, Jensenius M, Waggoner J, Leung D, Borwein S, Blumberg L, Schlagenhauf P, Barnett ED, Hamer DH, GeoSentinel Global Surveillance Network (2018)
    Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis
    PLoS Negl Trop Dis, 12 (11), e0006951
    DOI 10.1371/journal.pntd.0006951, PubMed 30422981
  10. Habtamu M, Abebe M, Aseffa A, Dyrhol-Riise AM, Spurkland A, Abrahamsen G (2018)
    In vitro analysis of antigen induced T cell-monocyte conjugates by imaging flow cytometry
    J Immunol Methods, 460, 93-100
    DOI 10.1016/j.jim.2018.06.014, PubMed 29981305
  11. Henjum K, Quist-Paulsen E, Zetterberg H, Blennow K, Nilsson LNG, Watne LO (2018)
    CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau
    J Neuroinflammation, 15 (1), 304
    DOI 10.1186/s12974-018-1331-1, PubMed 30390679
  12. Jenum S, Selvam S, Jesuraj N, Ritz C, Hesseling AC, Cardenas V, Lau E, Doherty TM, Grewal HMS, Vaz M (2018)
    Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: a cluster randomised trial in Indian neonates vaccinated with BCG
    BMJ Open Respir Res, 5 (1), e000304
    DOI 10.1136/bmjresp-2018-000304, PubMed 30397482
  13. Jourdan PM, Lamberton PHL, Fenwick A, Addiss DG (2018)
    Strongyloides stercoralis: the need for accurate information - Authors' reply
    Lancet, 391 (10137), 2323
    DOI 10.1016/S0140-6736(18)30858-4, PubMed 29900870
  14. Jørstad MD, Marijani M, Dyrhol-Riise AM, Sviland L, Mustafa T (2018)
    MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar
    PLoS One, 13 (5), e0196723
    DOI 10.1371/journal.pone.0196723, PubMed 29742144
  15. Lindland ES, Solheim AM, Andreassen S, Quist-Paulsen E, Eikeland R, Ljøstad U, Mygland Å, Elsais A, Nygaard GO, Lorentzen ÅR, Harbo HF, Beyer MK (2018)
    Imaging in Lyme neuroborreliosis
    Insights Imaging, 9 (5), 833-844
    DOI 10.1007/s13244-018-0646-x, PubMed 30187265
  16. Lothe A, Zulu N, Øyhus AO, Kjetland EF, Taylor M (2018)
    Treating schistosomiasis among South African high school pupils in an endemic area, a qualitative study
    BMC Infect Dis, 18 (1), 239
    DOI 10.1186/s12879-018-3102-0, PubMed 29801483
  17. Mocroft A, Laut K, Reiss P, Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O, Mulcahy F, Castagna A, Sthoeger Z, Flamholc L, Sedláček D, Mozer-Lisewska I, Lundgren JD, EuroSIDA Study (2018)
    Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
    AIDS, 32 (2), 205-215
    DOI 10.1097/QAD.0000000000001684, PubMed 29112060
  18. Myhrvold IK, Cremaschi A, Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia
    Oncotarget, 9 (10), 9273-9284
    DOI 10.18632/oncotarget.23949, PubMed 29507689
  19. Naess-Andresen K, Sorsvang L, Berntzen LS, Waehre T (2018)
    Pregnant HIV positive must be followed closely
    Tidsskr. Nor. Laegeforen., 138 (11), 998-999
  20. Orlien SMS, Ahmed TA, Ismael NY, Berhe N, Lauritzen T, Gundersen SG, Johannessen A (2018)
    High Seroprevalence of Autoantibodies Typical of Autoimmune Liver Disease in Eastern Ethiopia: Is Chewing of Khat (Catha edulis) a Triggering Factor?
    Can J Gastroenterol Hepatol, 2018, 4980597
    DOI 10.1155/2018/4980597, PubMed 30675469
  21. Orlien SMS, Ismael NY, Ahmed TA, Berhe N, Lauritzen T, Roald B, Goldin RD, Stene-Johansen K, Dyrhol-Riise AM, Gundersen SG, Morgan MY, Johannessen A (2018)
    Unexplained chronic liver disease in Ethiopia: a cross-sectional study
    BMC Gastroenterol, 18 (1), 27
    DOI 10.1186/s12876-018-0755-5, PubMed 29439653
  22. Orlien SMS, Sandven I, Berhe NB, Ismael NY, Ahmed TA, Stene-Johansen K, Gundersen SG, Morgan MY, Johannessen A (2018)
    Khat chewing increases the risk for developing chronic liver disease: A hospital-based case-control study
    Hepatology, 68 (1), 248-257
    DOI 10.1002/hep.29809, PubMed 29369368
  23. Pelchen-Matthews A, Ryom L, Borges ÁH, Edwards S, Duvivier C, Stephan C, Sambatakou H, Maciejewska K, Portu JJ, Weber J, Degen O, Calmy A, Reikvam DH, Jevtovic D, Wiese L, Smidt J, Smiatacz T, Hassoun G, Kuznetsova A, Clotet B, Lundgren J, Mocroft A, EuroSIDA study (2018)
    Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort
    AIDS, 32 (16), 2405-2416
    DOI 10.1097/QAD.0000000000001967, PubMed 30134296
  24. Quist-Paulsen E, Aukrust P, Kran AB, Dunlop O, Ormaasen V, Stiksrud B, Midttun Ø, Ueland T, Ueland PM, Mollnes TE, Dyrhol-Riise AM (2018)
    High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
    J Neuroinflammation, 15 (1), 327
    DOI 10.1186/s12974-018-1366-3, PubMed 30470234
  25. Sane Schepisi M, Navarra A, Altet Gomez MN, Dudnyk A, Dyrhol-Riise AM, Esteban J, Giorgetti PF, Gualano G, Guglielmetti L, Heyckendorf J, Kaluzhenina A, Lange B, Lange C, Manika K, Miah J, Nanovic Z, Pontali E, Prego MR, Solovic I, Tiberi S, Palmieri F, Girardi E (2018)
    Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study
    Open Forum Infect Dis, 6 (1), ofy337
    DOI 10.1093/ofid/ofy337, PubMed 30697572
  26. Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, White RA, Winje BA (2018)
    Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study
    BMC Infect Dis, 18 (1), 587
    DOI 10.1186/s12879-018-3468-z, PubMed 30453946
  27. Schlagenhauf P, Grobusch MP, Hamer DH, Asgeirsson H, Jensenius M, Eperon G, Rothe C, Isenring E, Fehr J, Schwartz E, Bottieau E, Barnett ED, McCarthy A, Kelly P, Schade Larsen C, van Genderen P, Stauffer W, Libman M, Gautret P (2018)
    Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis
    Malar J, 17 (1), 443
    DOI 10.1186/s12936-018-2586-9, PubMed 30497487
  28. Tveiten H, Brantsæter AB, Mengshoel AT (2018)
    Non-tuberculous mycobacterial pulmonary infections
    Tidsskr Nor Laegeforen, 138 (19)
    DOI 10.4045/tidsskr.18.0077, PubMed 30497255
  29. Ursin Rein P, Jacobsen D, Ormaasen V, Dunlop O (2018)
    Pneumococcal sepsis requiring mechanical ventilation: Cohort study in 38 patients with rapid progression to septic shock
    Acta Anaesthesiol Scand, 62 (10), 1428-1435
    DOI 10.1111/aas.13236, PubMed 30132782
  30. Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM (2018)
    Stratification by interferon-γ release assay level predicts risk of incident TB
    Thorax, 73 (7), 652-661
    DOI 10.1136/thoraxjnl-2017-211147, PubMed 29622693

Publications 2017

  1. Aberra H, Desalegn H, Berhe N, Medhin G, Stene-Johansen K, Gundersen SG, Johannessen A (2017)
    Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa
    BMC Infect Dis, 17 (1), 438
    DOI 10.1186/s12879-017-2549-8, PubMed 28629395
  2. Aberra H, Gordien E, Desalegn H, Berhe N, Medhin G, Mekasha B, Gundersen SG, Gerber A, Stene-Johansen K, Øverbø J, Johannessen A (2017)
    Hepatitis delta virus infection in a large cohort of chronic hepatitis B patients in Ethiopia
    Liver Int, 38 (6), 1000-1009
    DOI 10.1111/liv.13607, PubMed 28980394
  3. Al-Shudifat AE, Al-Shdaifat A, Al-Abdouh AA, Aburoman MI, Otoum SM, Sweedan AG, Khrais I, Abdel-Hafez IH, Johannessen A (2017)
    Diabetes Risk Score in a Young Student Population in Jordan: A Cross-Sectional Study
    J Diabetes Res, 2017, 8290710
    DOI 10.1155/2017/8290710, PubMed 28540309
  4. Al-Shudifat AE, Johannessen A, Azab M, Al-Shdaifat A, AbuMweis SS, Agraib LM, Tayyem RF (2017)
    Risk factors for coronary artery disease in patients undergoing elective coronary angiography in Jordan
    BMC Cardiovasc Disord, 17 (1), 183
    DOI 10.1186/s12872-017-0620-4, PubMed 28693430
  5. Bakke V, Sporsem H, Von der Lippe E, Nordøy I, Lao Y, Nyrerød HC, Sandvik L, Hårvig KR, Bugge JF, Helset E (2017)
    Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study
    Acta Anaesthesiol Scand, 61 (6), 627-635
    DOI 10.1111/aas.12897, PubMed 28444760
  6. Banhela N, Taylor M, Zulu SG, Strabo LS, Kjetland EF, Gundersen SG (2017)
    Environmental factors influencing the distribution and prevalence of Schistosoma haematobium in school attenders of ILembe and uThungulu Health Districts, KwaZulu-Natal Province, South Africa
    South. Afr. Infect. Dis., 32 (4), 132-137
  7. Bjerva M, Berild D, Jacobsen D (2017)
    [A well-trained man with mechanical aortic valve and leg pain]
    Tidsskr Nor Laegeforen, 137 (2), 113-116
    DOI 10.4045/tidsskr.15.1337, PubMed 28127075
  8. Brekke K, Sommerfelt M, Ökvist M, Dyrhol-Riise AM, Kvale D (2017)
    The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
    BMC Infect Dis, 17 (1), 228
    DOI 10.1186/s12879-017-2316-x, PubMed 28340570
  9. Chellappa S, Hugenschmidt H, Hagness M, Subramani S, Melum E, Line PD, Labori KJ, Wiedswang G, Taskén K, Aandahl EM (2017)
    CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer
    J Immunol, 198 (4), 1729-1739
    DOI 10.4049/jimmunol.1600061, PubMed 28053236
  10. Chu DT, Tao Y, Taskén K (2017)
    OPA1 in Lipid Metabolism: Function of OPA1 in Lipolysis and Thermogenesis of Adipocytes
    Horm Metab Res, 49 (4), 276-285
    DOI 10.1055/s-0043-100384, PubMed 28427098
  11. Desalegn H, Aberra H, Berhe N, Gundersen SG, Johannessen A (2017)
    Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?
    Liver Int, 37 (10), 1461-1467
    DOI 10.1111/liv.13393, PubMed 28222249
  12. Desalegn H, Johannessen A (2017)
    Response to Non-invasive fibrosis markers for chronic hepatitis B in sub-Saharan Africa
    Liver Int, 37 (11), 1739
    DOI 10.1111/liv.13425, PubMed 29065255
  13. Dukic AR, Haugen LH, Pidoux G, Leithe E, Bakke O, Taskén K (2017)
    A protein kinase A-ezrin complex regulates connexin 43 gap junction communication in liver epithelial cells
    Cell Signal, 32, 1-11
    DOI 10.1016/j.cellsig.2017.01.008, PubMed 28077322
  14. Feruglio SL, Kvale D, Dyrhol-Riise AM (2017)
    T Cell Responses and Regulation and the Impact of In Vitro IL-10 and TGF-β Modulation During Treatment of Active Tuberculosis
    Scand J Immunol, 85 (2), 138-146
    DOI 10.1111/sji.12511, PubMed 27862137
  15. Floeystad HK, Holm A, Sandvik L, Vestrheim DF, Brandsaeter B, Berild D (2017)
    Increased long-term mortality after survival of invasive pneumococcal disease: a population-based study
    Infect Dis (Lond), 49 (5), 365-372
    DOI 10.1080/23744235.2016.1271997, PubMed 28095723
  16. Freer JB, Bourke CD, Durhuus GH, Kjetland EF, Prendergast AJ (2017)
    Schistosomiasis in the first 1000 days
    Lancet Infect Dis, 18 (6), e193-e203
    DOI 10.1016/S1473-3099(17)30490-5, PubMed 29170089
  17. Gjøen JE, Jenum S, Sivakumaran D, Mukherjee A, Macaden R, Kabra SK, Lodha R, Ottenhoff THM, Haks MC, Doherty TM, Ritz C, Grewal HMS (2017)
    Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children
    Sci Rep, 7 (1), 5839
    DOI 10.1038/s41598-017-05057-x, PubMed 28724962
  18. Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, Berge RK, Gerstoft J, Ullum H, Trøseid M, Nielsen SD (2017)
    HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
    BMC Infect Dis, 17 (1), 234
    DOI 10.1186/s12879-017-2334-8, PubMed 28356058
  19. Jourdan PM, Lamberton PHL, Fenwick A, Addiss DG (2017)
    Soil-transmitted helminth infections
    Lancet, 391 (10117), 252-265
    DOI 10.1016/S0140-6736(17)31930-X, PubMed 28882382
  20. Jørgensen SB, Søraas A, Sundsfjord A, Liestøl K, Leegaard TM, Jenum PA (2017)
    Fecal carriage of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study
    PLoS One, 12 (3), e0173510
    DOI 10.1371/journal.pone.0173510, PubMed 28267783
  21. Leder K, Grobusch MP, Gautret P, Chen LH, Kuhn S, Lim PL, Yates J, McCarthy AE, Rothe C, Kato Y, Bottieau E, Huber K, Schwartz E, Stauffer W, Malvy D, Shaw MTM, Rapp C, Blumberg L, Jensenius M, van Genderen PJJ, Hamer DH, GeoSentinel Surveillance Network (2017)
    Zika beyond the Americas: Travelers as sentinels of Zika virus transmission. A GeoSentinel analysis, 2012 to 2016
    PLoS One, 12 (10), e0185689
    DOI 10.1371/journal.pone.0185689, PubMed 28973011
  22. Lingscheid T, Kurth F, Clerinx J, Marocco S, Trevino B, Schunk M, Muñoz J, Gjørup IE, Jelinek T, Develoux M, Fry G, Jänisch T, Schmid ML, Bouchaud O, Puente S, Zammarchi L, Mørch K, Björkman A, Siikamäki H, Neumayr A, Nielsen H, Hellgren U, Paul M, Calleri G, Kosina P et al. (2017)
    Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance Data
    Am J Trop Med Hyg, 97 (2), 567-574
    DOI 10.4269/ajtmh.17-0034, PubMed 28722637
  23. Manner IW, Waldum-Grevbo B, Witczak BN, Bækken M, Øktedalen O, Os I, Schwartz T, Sjaastad I (2017)
    Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients
    Blood Press, 26 (6), 332-340
    DOI 10.1080/08037051.2017.1346459, PubMed 28675304
  24. Mbatha JN, Galappaththi-Arachchige HN, Mtshali A, Taylor M, Ndhlovu PD, Kjetland EF, Baay MFD, Mkhize-Kwitshana ZL (2017)
    Self-sampling for human papillomavirus testing among rural young women of KwaZulu-Natal, South Africa
    BMC Res Notes, 10 (1), 702
    DOI 10.1186/s13104-017-3045-3, PubMed 29208043
  25. Mbatha JN, Taylor M, Kleppa E, Lillebo K, Galappaththi-Arachchige HN, Singh D, Kjetland EF, Baay MFD, Mkhize-Kwitshana ZL (2017)
    High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination
    Infect Dis (Lond), 49 (8), 601-608
    DOI 10.1080/23744235.2017.1312513, PubMed 28403727
  26. Molvik M, Helland E, Zulu SG, Kleppa E, Lillebo K, Gundersen SG, Kvalsvig JD, Taylor M, Kjetland EF, Vennervald BJ (2017)
    Co-infection with Schistosoma haematobium and soil-transmitted helminths in rural South Africa
    S. Afr. J. Sci., 113 (3-4), 2016-0251
  27. Musingwini TV, Zhou DT, Mhandire D, Duri K, Gomo E, Oktedalen O, Chimukangara B, Shamu T, Shawarira-Bote S, Dandara C, Stray-Pedersen B (2017)
    Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans
    Open Microbiol J, 11, 45-52
    DOI 10.2174/1874285801711010045, PubMed 28553415
  28. Muswe R, Oktedalen O, Zhou DT, Zinyando E, Shawarira-Bote S, Stray-Pedersen B, Siziba A, Gomo ZAR (2017)
    Inflammatory Markers and Plasma Lipids in HIV Patients: A Correlation Analysis Study
    Open Biochem J, 11, 105-118
    DOI 10.2174/1874091X01711010105, PubMed 29387269
  29. Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
    Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
    PLoS One, 12 (5), e0176527
    DOI 10.1371/journal.pone.0176527, PubMed 28464042
  30. Roaldsnes E, Eikeland R, Berild D (2017)
    Lyme neuroborreliosis in cases of non-specific neurological symptoms
    Tidsskr Nor Laegeforen, 137 (2), 101-104
    DOI 10.4045/tidsskr.15.1115, PubMed 28127071
  31. Tayyem RF, Al-Shudifat AE, Johannessen A, Bawadi HA, AbuMweis SS, Agraib LM, Allhedan SS, Haj-Husein I, Azab M (2017)
    Dietary patterns and the risk of coronary heart disease among Jordanians: A case-control study
    Nutr Metab Cardiovasc Dis, 28 (3), 262-269
    DOI 10.1016/j.numecd.2017.10.026, PubMed 29237548
  32. van Santen DK, van der Helm JJ, Del Amo J, Meyer L, D'Arminio Monforte A, Price M, Béguelin CA, Zangerle R, Sannes M, Porter K, Geskus RB, Prins M, CASCADE Collaboration in EuroCoord (2017)
    Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014
    J Hepatol, 67 (2), 255-262
    DOI 10.1016/j.jhep.2017.03.038, PubMed 28412290

Publications 2016

  1. Bains SJ, Mahic M, Myklebust TÅ, Småstuen MC, Yaqub S, Dørum LM, Bjørnbeth BA, Møller B, Brudvik KW, Taskén K (2016)
    Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study
    J Clin Oncol, 34 (21), 2501-8
    DOI 10.1200/JCO.2015.65.3519, PubMed 27247217
  2. Bates M, Brantsaeter AB (2016)
    Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
    J Virus Erad, 2 (3), 136-42
    PubMed 27482452
  3. Bustinduy AL, Friedman JF, Kjetland EF, Ezeamama AE, Kabatereine NB, Stothard JR, King CH (2016)
    Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
    PLoS Negl Trop Dis, 10 (9), e0004946
    DOI 10.1371/journal.pntd.0004946, PubMed 27658198
  4. Baan M, Galappaththi-Arachchige HN, Gagai S, Aurlund CG, Vennervald BJ, Taylor M, van Lieshout L, Kjetland EF (2016)
    The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa
    PLoS Negl Trop Dis, 10 (5), e0004623
    DOI 10.1371/journal.pntd.0004623, PubMed 27139497
  5. Dukic AR, McClymont DW, Taskén K (2016)
    A Cell-Based High-Throughput Assay for Gap Junction Communication Suitable for Assessing Connexin 43-Ezrin Interaction Disruptors Using IncuCyte ZOOM
    SLAS Discov, 22 (1), 77-85
    DOI 10.1177/1087057116669120, PubMed 27628689
  6. Eliassen KE, Berild D, Reiso H, Grude N, Christophersen KS, Finckenhagen C, Lindbæk M (2016)
    Incidence and antibiotic treatment of erythema migrans in Norway 2005-2009
    Ticks Tick Borne Dis, 8 (1), 1-8
    DOI 10.1016/j.ttbdis.2016.06.006, PubMed 27475874
  7. Galappaththi-Arachchige HN, Amlie Hegertun IE, Holmen S, Qvigstad E, Kleppa E, Sebitloane M, Ndhlovu PD, Vennervald BJ, Gundersen SG, Taylor M, Kjetland EF (2016)
    Association of Urogenital Symptoms with History of Water Contact in Young Women in Areas Endemic for S. haematobium. A Cross-Sectional Study in Rural South Africa
    Int J Environ Res Public Health, 13 (11)
    DOI 10.3390/ijerph13111135, PubMed 27854250
  8. Gautret P, Mockenhaupt F, Grobusch MP, Rothe C, von Sonnenburg F, van Genderen PJ, Chappuis F, Asgeirsson H, Caumes E, Bottieau E, Malvy D, Lopez-Vélez R, Jensenius M, Larsen CS, Castelli F, Rapp C, Field V, Molina I, Gkrania-Klotsas E, Florescu S, Lalloo D, Schlagenhauf P (2016)
    Arboviral and other illnesses in travellers returning from Brazil, June 2013 to May 2016: implications for the 2016 Olympic and Paralympic Games
    Euro Surveill, 21 (27)
    DOI 10.2807/1560-7917.ES.2016.21.27.30278, PubMed 27416907
  9. Haissman JM, Knudsen A, Hoel H, Kjær A, Kristoffersen US, Berge RK, Katzenstein TL, Svardal A, Ueland T, Aukrust P, Lebech AM, Nielsen SD, Trøseid M (2016)
    Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection
    J Acquir Immune Defic Syndr, 71 (2), 130-6
    DOI 10.1097/QAI.0000000000000843, PubMed 26413854
  10. Holmen S, Galappaththi-Arachchige HN, Kleppa E, Pillay P, Naicker T, Taylor M, Onsrud M, Kjetland EF, Albregtsen F (2016)
    Characteristics of Blood Vessels in Female Genital Schistosomiasis: Paving the Way for Objective Diagnostics at the Point of Care
    PLoS Negl Trop Dis, 10 (4), e0004628
    DOI 10.1371/journal.pntd.0004628, PubMed 27073857
  11. Jensenius M, Winje BA, Blomberg B, Mengshoel AT, Lippe Bv, Hannula R, Bruun JN, Knudsen PK, Rønning JO, Heldal E, Dyrhol-Riise AM (2016)
    Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014
    Int J Tuberc Lung Dis, 20 (6), 786-92
    DOI 10.5588/ijtld.15.0895, PubMed 27155182
  12. Jenum S, Bakken R, Dhanasekaran S, Mukherjee A, Lodha R, Singh S, Singh V, Haks MC, Ottenhoff TH, Kabra SK, Doherty TM, Ritz C, Grewal HM (2016)
    BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome
    Sci Rep, 6, 38841
    DOI 10.1038/srep38841, PubMed 27941850
  13. Jenum S, Dhanasekaran S, Ritz C, Macaden R, Doherty TM, Grewal HM, TB Trials Study Group (2016)
    Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis: Specific Immunity in Young Children
    Pediatr Infect Dis J, 35 (12), 1336-1338
    DOI 10.1097/INF.0000000000001328, PubMed 27642776
  14. Jespersen S, Pedersen KK, Anesten B, Zetterberg H, Fuchs D, Gisslén M, Hagberg L, Trøseid M, Nielsen SD (2016)
    Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study
    BMC Infect Dis, 16, 176
    DOI 10.1186/s12879-016-1510-6, PubMed 27103116
  15. Kodogo V, Zhou DT, Oektedalen O, Duri K, Stray-Pedersen B, Gomo E (2016)
    Apolipoprotein B Gene Polymorphisms and Dyslipidemia in HIV Infected Adult Zimbabweans
    Open AIDS J, 10, 190-198
    DOI 10.2174/1874613601610010190, PubMed 27790293
  16. Liu LL, Landskron J, Ask EH, Enqvist M, Sohlberg E, Traherne JA, Hammer Q, Goodridge JP, Larsson S, Jayaraman J, Oei VYS, Schaffer M, Taskén K, Ljunggren HG, Romagnani C, Trowsdale J, Malmberg KJ, Béziat V (2016)
    Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
    Cell Rep, 15 (5), 1088-1099
    DOI 10.1016/j.celrep.2016.04.005, PubMed 27117418
  17. Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O (2016)
    Hepatitis C reinfection after sustained virological response
    J Hepatol, 64 (5), 1020-1026
    DOI 10.1016/j.jhep.2016.01.001, PubMed 26780289
  18. Moltu K, Henjum K, Oberprieler NG, Bjørnbeth BA, Taskén K (2016)
    Proximal signaling responses in peripheral T cells from colorectal cancer patients are affected by high concentrations of circulating prostaglandin E2
    Hum Immunol, 78 (2), 129-137
    DOI 10.1016/j.humimm.2016.10.007, PubMed 27769746
  19. Nielsen HG, Øktedalen O, Opstad PK, Lyberg T (2016)
    Plasma Cytokine Profiles in Long-Term Strenuous Exercise
    J Sports Med (Hindawi Publ Corp), 2016, 7186137
    DOI 10.1155/2016/7186137, PubMed 27239554
  20. Pillay P, van Lieshout L, Taylor M, Sebitloane M, Zulu SG, Kleppa E, Roald B, Kjetland EF (2016)
    Cervical cytology as a diagnostic tool for female genital schistosomiasis: Correlation to cervical atypia and Schistosoma polymerase chain reaction
    Cytojournal, 13, 10
    DOI 10.4103/1742-6413.180784, PubMed 27168759
  21. Prebensen C, Lind A, Dyrhol-Riise AM, Kvale D (2016)
    Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
    PLoS One, 11 (4), e0153849
    DOI 10.1371/journal.pone.0153849, PubMed 27128502
  22. Sisay Z, Djikeng A, Berhe N, Belay G, Abegaz WE, Wang QH, Saif LJ (2016)
    First detection and molecular characterization of sapoviruses and noroviruses with zoonotic potential in swine in Ethiopia
    Arch Virol, 161 (10), 2739-47
    DOI 10.1007/s00705-016-2974-9, PubMed 27424025
  23. Stene-Johansen K, Yaqoob N, Overbo J, Aberra H, Desalegn H, Berhe N, Johannessen A (2016)
    Dry Blood Spots a Reliable Method for Measurement of Hepatitis B Viral Load in Resource-Limited Settings
    PLoS One, 11 (11), e0166201
    DOI 10.1371/journal.pone.0166201, PubMed 27820845
  24. Stiksrud B, Lorvik KB, Kvale D, Mollnes TE, Ueland PM, Trøseid M, Taskén K, Dyrhol-Riise AM (2016)
    Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts
    J Acquir Immune Defic Syndr, 73 (2), 138-48
    DOI 10.1097/QAI.0000000000001080, PubMed 27632144
  25. Stubhaug TT, Reiakvam OM, Stensvold CR, Hermansen NO, Holberg-Petersen M, Antal EA, Gaustad K, Førde IS, Heger B (2016)
    Fatal primary amoebic meningoencephalitis in a Norwegian tourist returning from Thailand
    JMM Case Rep, 3 (3), e005042
    DOI 10.1099/jmmcr.0.005042, PubMed 28348761
  26. Tonby K, Wergeland I, Lieske NV, Kvale D, Tasken K, Dyrhol-Riise AM (2016)
    The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
    BMC Infect Dis, 16 (1), 599
    DOI 10.1186/s12879-016-1938-8, PubMed 27776487
  27. Uyeki TM, Mehta AK, Davey RT, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J, Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe (2016)
    Clinical Management of Ebola Virus Disease in the United States and Europe
    N Engl J Med, 374 (7), 636-46
    DOI 10.1056/NEJMoa1504874, PubMed 26886522
  28. Wehbi VL, Taskén K (2016)
    Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units
    Front Immunol, 7, 222
    DOI 10.3389/fimmu.2016.00222, PubMed 27375620
  29. Wergeland I, Assmus J, Dyrhol-Riise AM (2016)
    Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls
    PLoS One, 11 (9), e0163848
    DOI 10.1371/journal.pone.0163848, PubMed 27685462
  30. Waagsbø B, Svardal A, Ueland T, Landrø L, Øktedalen O, Berge RK, Flo TH, Aukrust P, Damås JK (2016)
    Low levels of short- and medium-chain acylcarnitines in HIV-infected patients
    Eur J Clin Invest, 46 (5), 408-17
    DOI 10.1111/eci.12609, PubMed 26913383
  31. Zhou DT, Nehumba D, Oktedalen O, Marange P, Kodogo V, Gomo ZA, Esterhuizen TM, Stray-Pedersen B (2016)
    Changes in Lipid Profiles of HIV(+) Adults over Nine Months at a Harare HIV Clinic: A Longitudinal Study
    Biochem Res Int, 2016, 3204818
    DOI 10.1155/2016/3204818, PubMed 27051532
  32. Zhou DT, Oektedalen O, Shawarira-Bote S, Stray-Pedersen B (2016)
    Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study
    HIV AIDS (Auckl), 8, 165-174
    DOI 10.2147/HIV.S113206, PubMed 27822124

Publications 2015

  1. Aske H, Anong SA, Roald B, Salpou D, Jourdan PM (2015)
    Febrile Illness and Intravenous Antimalarial Treatment at a District Hospital in Cameroon
    West Afr J Med, 34 (1), 55-61
    PubMed 26902818
  2. Berild D (2015)
    [An unusual cause of back pain]
    Tidsskr Nor Laegeforen, 135 (4), 343-4
    DOI 10.4045/tidsskr.15.0047, PubMed 25707660
  3. Brandsæter B, Aaberge IS, Dunlop O (2015)
    Tetanus after a minor injury leading to death in a previously non-immunized, elderly, Norwegian woman
    IDCases, 2 (2), 53-5
    DOI 10.1016/j.idcr.2015.03.003, PubMed 26793455
  4. Chellappa S, Hugenschmidt H, Hagness M, Line PD, Labori KJ, Wiedswang G, Taskén K, Aandahl EM (2015)
    Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
    Oncoimmunology, 5 (4), e1102828
    DOI 10.1080/2162402X.2015.1102828, PubMed 27141387
  5. Chellappa S, Lieske NV, Hagness M, Line PD, Taskén K, Aandahl EM (2015)
    Human regulatory T cells control TCR signaling and susceptibility to suppression in CD4+ T cells
    J Leukoc Biol, 100 (1), 5-16
    DOI 10.1189/jlb.2HI0815-334R, PubMed 26715685
  6. Dhondup Y, Sjaastad I, Scott H, Sandanger Ø, Zhang L, Haugstad SB, Aronsen JM, Ranheim T, Holmen SD, Alfsnes K, Ahmed MS, Attramadal H, Gullestad L, Aukrust P, Christensen G, Yndestad A, Vinge LE (2015)
    Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
    PLoS One, 10 (10), e0139715
    DOI 10.1371/journal.pone.0139715, PubMed 26461521
  7. Feruglio SL, Tonby K, Kvale D, Dyrhol-Riise AM (2015)
    Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
    Clin Exp Immunol, 179 (3), 454-65
    DOI 10.1111/cei.12468, PubMed 25313008
  8. Gerbaud P, Taskén K, Pidoux G (2015)
    Spatiotemporal regulation of cAMP signaling controls the human trophoblast fusion
    Front Pharmacol, 6, 202
    DOI 10.3389/fphar.2015.00202, PubMed 26441659
  9. Gaardbo JC, Trøsied M, Stiksrud B, Midttun Ø, Ueland PM, Ullum H, Nielsen SD (2015)
    Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up
    J Acquir Immune Defic Syndr, 70 (3), 228-35
    DOI 10.1097/QAI.0000000000000758, PubMed 26470032
  10. Hartling HJ, Birch C, Gaardbo JC, Hove M, Trøseid M, Clausen MR, Gerstoft J, Ullum H, Nielsen SD (2015)
    T-cell homeostasis in chronic HCV-infected patients treated with interferon and ribavirin or an interferon-free regimen
    APMIS, 123 (10), 903-11
    DOI 10.1111/apm.12429, PubMed 26279289
  11. Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M et al. (2015)
    Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
    Clin Infect Dis, 62 (5), 655-663
    DOI 10.1093/cid/civ963, PubMed 26620652
  12. Holmen SD, Kjetland EF, Taylor M, Kleppa E, Lillebø K, Gundersen SG, Onsrud M, Albregtsen F (2015)
    Colourimetric image analysis as a diagnostic tool in female genital schistosomiasis
    Med Eng Phys, 37 (3), 309-14
    DOI 10.1016/j.medengphy.2014.12.007, PubMed 25630808
  13. Holmen SD, Kleppa E, Lillebø K, Pillay P, van Lieshout L, Taylor M, Albregtsen F, Vennervald BJ, Onsrud M, Kjetland EF (2015)
    The first step toward diagnosing female genital schistosomiasis by computer image analysis
    Am J Trop Med Hyg, 93 (1), 80-86
    DOI 10.4269/ajtmh.15-0071, PubMed 25918212
  14. Haabeth OA, Lorvik KB, Yagita H, Bogen B, Corthay A (2015)
    Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
    Oncoimmunology, 5 (1), e1039763
    DOI 10.1080/2162402X.2015.1039763, PubMed 26942052
  15. Johannessen A (2015)
    Where we are with point-of-care testing
    J Viral Hepat, 22 (4), 362-5
    DOI 10.1111/jvh.12385, PubMed 25762459
  16. Johannessen A, Lemoine M (2015)
    Is aspartate aminotransferase-to-platelet ratio index a reliable tool in human immunodeficiency virus patients in Africa?
    Liver Int, 35 (8), 2059
    DOI 10.1111/liv.12793, PubMed 25646656
  17. Kildemoes AO, Kjetland EF, Zulu SG, Taylor M, Vennervald BJ (2015)
    Schistosoma haematobium infection and asymptomatic bacteriuria in young South African females
    Acta Trop, 144, 19-23
    DOI 10.1016/j.actatropica.2015.01.008, PubMed 25623258
  18. Kleppa E, Klinge KF, Galaphaththi-Arachchige HN, Holmen SD, Lillebø K, Onsrud M, Gundersen SG, Taylor M, Ndhlovu P, Kjetland EF (2015)
    Schistosoma haematobium infection and CD4+ T-cell levels: a cross-sectional study of young South African women
    PLoS One, 10 (3), e0119326
    DOI 10.1371/journal.pone.0119326, PubMed 25768005
  19. Lieske NV, Tonby K, Kvale D, Dyrhol-Riise AM, Tasken K (2015)
    Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
    PLoS One, 10 (11), e0141903
    DOI 10.1371/journal.pone.0141903, PubMed 26544592
  20. Magaisa K, Taylor M, Kjetland EF, Naidoo PJ (2015)
    A review of the control of schistosomiasis in South Africa
    S. Afr. J. Sci., 111 (11-12), 2014-0427-37
  21. Mekonnen SK, Medhin G, Berhe N, Clouse RM, Aseffa A (2015)
    Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia
    Malar J, 14, 317
    DOI 10.1186/s12936-015-0826-9, PubMed 26271736
  22. Myrvang B (2015)
    Manson's tropical diseases
    Tidsskr. Nor. Laegeforen., 135 (2), 158
  23. Nowak P, Troseid M, Avershina E, Barqasho B, Neogi U, Holm K, Hov JR, Noyan K, Vesterbacka J, Svärd J, Rudi K, Sönnerborg A (2015)
    Gut microbiota diversity predicts immune status in HIV-1 infection
    AIDS, 29 (18), 2409-18
    DOI 10.1097/QAD.0000000000000869, PubMed 26355675
  24. Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA (2015)
    Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
    Haematologica, 101 (2), e59-62
    DOI 10.3324/haematol.2015.135590, PubMed 26589914
  25. Pedersen KK, Eiersted MR, Gaardbo JC, Pedersen M, Gerstoft J, Troseid M, Nielsen SD (2015)
    Lower Self-Reported Quality of Life in HIV-Infected Patients on cART and With Low Comorbidity Compared With Healthy Controls
    J Acquir Immune Defic Syndr, 70 (1), 16-22
    DOI 10.1097/QAI.0000000000000697, PubMed 26017659
  26. Pidoux G, Taskén K (2015)
    Anchored PKA as a gatekeeper for gap junctions
    Commun Integr Biol, 8 (4), e1057361
    DOI 10.1080/19420889.2015.1057361, PubMed 26478781
  27. Podolsky SH, Bud R, Gradmann C, Hobaek B, Kirchhelle C, Mitvedt T, Santesmases MJ, Thoms U, Berild D, Kveim Lie A (2015)
    History Teaches Us That Confronting Antibiotic Resistance Requires Stronger Global Collective Action
    J Law Med Ethics, 43 Suppl 3, 27-32
    DOI 10.1111/jlme.12271, PubMed 26243240
  28. Prebensen C, Ueland T, Michelsen AE, Lind A, Pettersen FO, Mollnes TE, Aukrust P, Dyrhol-Riise AM, Kvale D (2015)
    High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
    J Acquir Immune Defic Syndr, 69 (4), 395-402
    DOI 10.1097/QAI.0000000000000617, PubMed 26115437
  29. Randjelovic A, Fronsa SG, Munsami M, Kvalsvig JD, Zulu SG, Gagai S, Maphumulo A, Sandvik L, Gundersen SG, Kjetland EF, Taylor M (2015)
    A study of hurdles in mass treatment of schistosomiasis in KwaZulu-Natal, South Africa
    S AFR FAM PRACT, 57 (2), 57-61
  30. Randrianasolo BS, Jourdan PM, Ravoniarimbinina P, Ramarokoto CE, Rakotomanana F, Ravaoalimalala VE, Gundersen SG, Feldmeier H, Vennervald BJ, van Lieshout L, Roald B, Leutscher P, Kjetland EF (2015)
    Gynecological manifestations, histopathological findings, and schistosoma-specific polymerase chain reaction results among women with Schistosoma haematobium infection: a cross-sectional study in Madagascar
    J Infect Dis, 212 (2), 275-84
    DOI 10.1093/infdis/jiv035, PubMed 25725656
  31. Raslan Z, Magwenzi S, Aburima A, Taskén K, Naseem KM (2015)
    Targeting of type I protein kinase A to lipid rafts is required for platelet inhibition by the 3',5'-cyclic adenosine monophosphate-signaling pathway
    J Thromb Haemost, 13 (9), 1721-34
    DOI 10.1111/jth.13042, PubMed 26176741
  32. Riise AMD (2015)
    Our Voices HIV: 30 years in Norway
    Tidsskr. Nor. Laegeforen., 135 (19), 1769
  33. Raastad R, Tvete IF, Abrahamsen TG, Berild D, Leegaard TM, Walberg M, Müller F (2015)
    A worrying trend in weight-adjusted paediatric antibiotic use in a Norwegian tertiary care hospital
    Acta Paediatr, 104 (7), 687-92
    DOI 10.1111/apa.12994, PubMed 25753620
  34. Santegoets SJ, Dijkgraaf EM, Battaglia A, Beckhove P, Britten CM, Gallimore A, Godkin A, Gouttefangeas C, de Gruijl TD, Koenen HJ, Scheffold A, Shevach EM, Staats J, Taskén K, Whiteside TL, Kroep JR, Welters MJ, van der Burg SH (2015)
    Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
    Cancer Immunol Immunother, 64 (10), 1271-86
    DOI 10.1007/s00262-015-1729-x, PubMed 26122357
  35. Stecher CW, Kallestrup P, Kjetland EF, Vennervald B, Petersen E (2015)
    Considering treatment of male genital schistosomiasis as a tool for future HIV prevention: a systematic review
    Int J Public Health, 60 (7), 839-48
    DOI 10.1007/s00038-015-0714-7, PubMed 26298443
  36. Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AE, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Trøseid M (2015)
    Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
    J Acquir Immune Defic Syndr, 70 (4), 329-37
    DOI 10.1097/QAI.0000000000000784, PubMed 26258571
  37. Tonby K, Ruhwald M, Kvale D, Dyrhol-Riise AM (2015)
    IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
    Sci Rep, 5, 9223
    DOI 10.1038/srep09223, PubMed 25783975
  38. Trøseid M, Nestvold TK, Nielsen EW, Thoresen H, Seljeflot I, Lappegård KT (2015)
    Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients
    Metab Syndr Relat Disord, 13 (3), 119-24
    DOI 10.1089/met.2014.0111, PubMed 25562385
  39. Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, Kvale D, Damås JK, Aukrust P, Mollnes TE, Dyrhol-Riise AM (2015)
    IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
    J Infect, 70 (4), 381-91
    DOI 10.1016/j.jinf.2014.12.019, PubMed 25597826
  40. Zhou DT, Kodogo V, Chokuona KF, Gomo E, Oektedalen O, Stray-Pedersen B (2015)
    Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe
    HIV AIDS (Auckl), 7, 145-55
    DOI 10.2147/HIV.S78523, PubMed 25999764

Publications 2014

  1. Astrup E, Ranheim T, Damås JK, Davì G, Santilli F, Jensenius M, Vitale G, Aukrust P, Olano JP, Otterdal K (2014)
    Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection
    BMC Infect Dis, 14, 70
    DOI 10.1186/1471-2334-14-70, PubMed 24507453
  2. Brekke K, Lind A, Holm-Hansen C, Haugen IL, Sørensen B, Sommerfelt M, Kvale D (2014)
    Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial
    PLoS One, 9 (11), e112556
    DOI 10.1371/journal.pone.0112556, PubMed 25398137
  3. Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F (2014)
    Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
    Genome Biol, 15 (11), 490
    DOI 10.1186/s13059-014-0490-3, PubMed 25418686
  4. Ellinger B, Silber J, Prashar A, Landskron J, Weber J, Rehermann S, Müller FJ, Smith S, Wrigley S, Taskén K, Gribbon P, Labes A, Imhoff JF (2014)
    A phenotypic screening approach to identify anticancer compounds derived from marine fungi
    Assay Drug Dev Technol, 12 (3), 162-75
    DOI 10.1089/adt.2013.564, PubMed 24735443
  5. Halvorsen B, Smedbakken LM, Michelsen AE, Skjelland M, Bjerkeli V, Sagen EL, Taskén K, Bendz B, Gullestad L, Holm S, Biessen EA, Aukrust P (2014)
    Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13
    Atherosclerosis, 234 (2), 352-9
    DOI 10.1016/j.atherosclerosis.2014.03.021, PubMed 24732574
  6. Haug JB, Berild D, Walberg M, Reikvam Å (2014)
    Hospital- and patient-related factors associated with differences in hospital antibiotic use: analysis of national surveillance results
    Antimicrob Resist Infect Control, 3 (1), 40
    DOI 10.1186/s13756-014-0040-5, PubMed 25598971
  7. Hesstvedt L, Reikvam DH, Dunlop O (2014)
    Neurological melioidosis in Norway presenting with a cerebral abscess
    IDCases, 2 (1), 16-8
    DOI 10.1016/j.idcr.2014.11.001, PubMed 26793441
  8. Kjetland EF, Hegertun IE, Baay MF, Onsrud M, Ndhlovu PD, Taylor M (2014)
    Genital schistosomiasis and its unacknowledged role on HIV transmission in the STD intervention studies
    Int J STD AIDS, 25 (10), 705-15
    DOI 10.1177/0956462414523743, PubMed 24621458
  9. Kjetland EF, Norseth HM, Taylor M, Lillebø K, Kleppa E, Holmen SD, Andebirhan A, Yohannes TH, Gundersen SG, Vennervald BJ, Bagratee J, Onsrud M, Leutscher PD (2014)
    Classification of the lesions observed in female genital schistosomiasis
    Int J Gynaecol Obstet, 127 (3), 227-8
    DOI 10.1016/j.ijgo.2014.07.014, PubMed 25179171
  10. Kleppa E, Holmen SD, Lillebø K, Kjetland EF, Gundersen SG, Taylor M, Moodley P, Onsrud M (2014)
    Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South Africa
    Sex Transm Infect, 91 (2), 124-9
    DOI 10.1136/sextrans-2014-051674, PubMed 25281761
  11. Kleppa E, Ramsuran V, Zulu S, Karlsen GH, Bere A, Passmore JA, Ndhlovu P, Lillebø K, Holmen SD, Onsrud M, Gundersen SG, Taylor M, Kjetland EF, Ndung'u T (2014)
    Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract
    PLoS One, 9 (6), e98593
    DOI 10.1371/journal.pone.0098593, PubMed 24896815
  12. Kran AMB, Lind A, Sommerfelt MM, Baksaas I, Sørensen B, Kvale D (2014)
    Comparable Cellular Immune Responses in Patients with and without Antiretroviral Treatment after Immunization with HIV-1 P24, P17 and Tat Consensus Peptides (Vacc-5q)
    J AIDS Clin Res, 5 (4), 1000294
    DOI 10.4172/2155-6113.1000296, PublikaID 217
  13. Landskron J, Helland Ø, Torgersen KM, Aandahl EM, Gjertsen BT, Bjørge L, Taskén K (2014)
    Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients
    Cancer Immunol Immunother, 64 (3), 337-47
    DOI 10.1007/s00262-014-1636-6, PubMed 25416072
  14. Lind A, Brekke K, Pettersen FO, Mollnes TE, Trøseid M, Kvale D (2014)
    A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
    PLoS One, 9 (1), e85604
    DOI 10.1371/journal.pone.0085604, PubMed 24416431
  15. Maeland A (2014)
    Antiretroviral treatment initiation
    Lancet Infect Dis, 14 (12), 1175
    DOI 10.1016/S1473-3099(14)70947-8, PubMed 25455976
  16. Manner IW, Baekken M, Oektedalen O, Kvale D, Nowak P, Nielsen SD, Os I, Trøseid M (2014)
    Plasma lipopolysaccharide and triglycerides are independently associated and both markers correlate with the development of metabolic syndrome in HIV infection
    J Acquir Immune Defic Syndr, 65 (4), e158-61
    DOI 10.1097/QAI.0000000000000055, PubMed 24577189
  17. Mocroft A, Ryom L, Begovac J, Monforte AD, Vassilenko A, Gatell J, Florence E, Ormaasen V, Kirk O, Lundgren JD, EuroSIDA in EuroCOORD (2014)
    Deteriorating renal function and clinical outcomes in HIV-positive persons
    AIDS, 28 (5), 727-37
    DOI 10.1097/QAD.0000000000000134, PubMed 24983543
  18. Norseth HM, Ndhlovu PD, Kleppa E, Randrianasolo BS, Jourdan PM, Roald B, Holmen SD, Gundersen SG, Bagratee J, Onsrud M, Kjetland EF (2014)
    The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi, Zimbabwe, Madagascar and South Africa
    PLoS Negl Trop Dis, 8 (11), e3229
    DOI 10.1371/journal.pntd.0003229, PubMed 25412334
  19. Odolini S, Gautret P, Kain KC, Smith K, Leder K, Jensenius M, Coyle CM, Castelli F, Matteelli A (2014)
    Imported Plasmodium vivax malaria ex Pakistan
    J Travel Med, 21 (5), 314-7
    DOI 10.1111/jtm.12134, PubMed 24889386
  20. Olson AD, Guiguet M, Zangerle R, Gill J, Perez-Hoyos S, Lodi S, Ghosn J, Dorrucci M, Johnson A, Sannes M, Moreno S, Porter K, for CASCADE Collaboration in EuroCoord (2014)
    Evaluation of rapid progressors in HIV infection as an extreme phenotype
    J Acquir Immune Defic Syndr, 67 (1), 15-21
    DOI 10.1097/QAI.0000000000000240, PubMed 24872130
  21. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
    Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
    J Acquir Immune Defic Syndr, 67 (4), 370-4
    DOI 10.1097/QAI.0000000000000339, PubMed 25226210
  22. Pettersen PS, Brox IK, Naman E, Bruun JN, Dyrhol-Riise AM, Trøseid M, Johannessen A (2014)
    Antiretroviral treatment failure predicts mortality in rural Tanzania
    Int J STD AIDS, 26 (9), 633-9
    DOI 10.1177/0956462414548460, PubMed 25122578
  23. Pidoux G, Gerbaud P, Dompierre J, Lygren B, Solstad T, Evain-Brion D, Taskén K (2014)
    A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion
    J Cell Sci, 127 (Pt 19), 4172-85
    DOI 10.1242/jcs.149609, PubMed 25052094
  24. Pillay P, Taylor M, Zulu SG, Gundersen SG, Verweij JJ, Hoekstra P, Brienen EA, Kleppa E, Kjetland EF, van Lieshout L (2014)
    Real-time polymerase chain reaction for detection of Schistosoma DNA in small-volume urine samples reflects focal distribution of urogenital Schistosomiasis in primary school girls in KwaZulu Natal, South Africa
    Am J Trop Med Hyg, 90 (3), 546-52
    DOI 10.4269/ajtmh.13-0406, PubMed 24470560
  25. Pullar ND, Steinum H, Tonby K, Heggelund L, Leiva RA, Ofstad R, Bruun JN, Dyrhol-Riise AM (2014)
    Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway
    Int J Tuberc Lung Dis, 18 (2), 180-7
    DOI 10.5588/ijtld.13.0276, PubMed 24429310
  26. Ramarokoto CE, Kildemoes AO, Randrianasolo BS, Ravoniarimbinina P, Ravaoalimalala VE, Leutscher P, Kjetland EF, Vennervald BJ (2014)
    Eosinophil granule proteins ECP and EPX as markers for a potential early-stage inflammatory lesion in female genital schistosomiasis (FGS)
    PLoS Negl Trop Dis, 8 (7), e2974
    DOI 10.1371/journal.pntd.0002974, PubMed 25033206
  27. Rogne M, Taskén K (2014)
    Compartmentalization of cAMP signaling in adipogenesis, lipogenesis, and lipolysis
    Horm Metab Res, 46 (12), 833-40
    DOI 10.1055/s-0034-1389955, PubMed 25247872
  28. Rolseth S, Stange P, Adamou D, Roald B, Danki-Sillong F, Jourdan P (2014)
    The acceptability of volunteer, repeat blood donations in a hospital setting in the Adamaoua region of Cameroon
    Transfus Med, 24 (6), 372-8
    DOI 10.1111/tme.12156, PubMed 25263087
  29. Schlagenhauf P, Weld L, Goorhuis A, Gautret P, Weber R, von Sonnenburg F, Lopez-Vélez R, Jensenius M, Cramer JP, Field VK, Odolini S, Gkrania-Klotsas E, Chappuis F, Malvy D, van Genderen PJ, Mockenhaupt F, Jauréguiberry S, Smith C, Beeching NJ, Ursing J, Rapp C, Parola P, Grobusch MP, EuroTravNet (2014)
    Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation
    Lancet Infect Dis, 15 (1), 55-64
    DOI 10.1016/S1473-3099(14)71000-X, PubMed 25477022
  30. Skånland SS, Moltu K, Berge T, Aandahl EM, Taskén K (2014)
    T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responses
    Biochem J, 460 (3), 399-410
    DOI 10.1042/BJ20140040, PubMed 24665965
  31. Spurgeon BE, Aburima A, Oberprieler NG, Taskén K, Naseem KM (2014)
    Multiplexed phosphospecific flow cytometry enables large-scale signaling profiling and drug screening in blood platelets
    J Thromb Haemost, 12 (10), 1733-43
    DOI 10.1111/jth.12670, PubMed 25056834
  32. Trøseid M, Ditlevsen S, Hvid T, Gerstoft J, Grøndahl T, Pedersen BK, Nielsen SD, Lindegaard B (2014)
    Reduced trunk fat and triglycerides after strength training are associated with reduced LPS levels in HIV-infected individuals
    J Acquir Immune Defic Syndr, 66 (2), e52-4
    DOI 10.1097/QAI.0000000000000132, PubMed 24608893
  33. Trøseid M, Manner IW, Pedersen KK, Haissman JM, Kvale D, Nielsen SD (2014)
    Microbial translocation and cardiometabolic risk factors in HIV infection
    AIDS Res Hum Retroviruses, 30 (6), 514-22
    DOI 10.1089/aid.2013.0280, PubMed 24521167
  34. Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH, Aukrust P, Gullestad L, Berge RK, Yndestad A (2014)
    Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
    J Intern Med, 277 (6), 717-26
    DOI 10.1111/joim.12328, PubMed 25382824
  35. Warne B, Weld LH, Cramer JP, Field VK, Grobusch MP, Caumes E, Jensenius M, Gautret P, Schlagenhauf P, Castelli F, Lalloo DG, Ursing J, Chappuis F, von Sonnenburg F, López-Vélez R, Rapp C, Smith KC, Parola P, Gkrania-Klotsas E, EuroTravNet Network (2014)
    Travel-related infection in European travelers, EuroTravNet 2011
    J Travel Med, 21 (4), 248-54
    DOI 10.1111/jtm.12120, PubMed 24750378
  36. Wilson ME, Chen LH, Han PV, Keystone JS, Cramer JP, Segurado A, Hale D, Jensenius M, Schwartz E, von Sonnenburg F, Leder K, GeoSentinel Surveillance Network (2014)
    Illness in travelers returned from Brazil: the GeoSentinel experience and implications for the 2014 FIFA World Cup and the 2016 Summer Olympics
    Clin Infect Dis, 58 (10), 1347-56
    DOI 10.1093/cid/ciu122, PubMed 24585698
  37. Wæhre T, Maagard A, Tappe D, Cadar D, Schmidt-Chanasit J (2014)
    Zika virus infection after travel to Tahiti, December 2013
    Emerg Infect Dis, 20 (8), 1412-4
    DOI 10.3201/eid2008.140302, PubMed 25062427
  38. Aavitsland P, Berild D, Emmert A, Horn M, Rørtveit G (2014)
    [Scientificity and justifiability]
    Tidsskr Nor Laegeforen, 134 (2), 138-9
    DOI 10.4045/tidsskr.13.1682, PubMed 24477133

Publications 2013

  1. Andersson LM, Vesterbacka J, Blaxhult A, Flamholc L, Nilsson S, Ormaasen V, Sönnerborg A, Gisslén M (2013)
    Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial
    Scand J Infect Dis, 45 (7), 543-51
    DOI 10.3109/00365548.2012.756985, PubMed 23294034
  2. Cornez I, Joel M, Taskén K, Langmoen IA, Glover JC, Berge T (2013)
    EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry
    J Neurooncol, 112 (1), 49-57
    DOI 10.1007/s11060-012-1035-9, PubMed 23299461
  3. Drozd F, Skeie LG, Kraft P, Kvale D (2013)
    A web-based intervention trial for depressive symptoms and subjective well-being in patients with chronic HIV infection
    AIDS Care, 26 (9), 1080-9
    DOI 10.1080/09540121.2013.869541, PubMed 24359563
  4. Ehehalt U, Schunk M, Jensenius M, van Genderen PJ, Gkrania-Klotsas E, Chappuis F, Schlagenhauf P, Castelli F, Lopez-Velez R, Parola P, Burchard GD, Cramer JP (2013)
    Leishmaniasis acquired by travellers to endemic regions in Europe: a EuroTravNet multi-centre study
    Travel Med Infect Dis, 12 (2), 167-72
    DOI 10.1016/j.tmaid.2013.12.003, PubMed 24388687
  5. Feruglio SL, Trøseid M, Damås JK, Kvale D, Dyrhol-Riise AM (2013)
    Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses
    PLoS One, 8 (7), e69896
    DOI 10.1371/journal.pone.0069896, PubMed 23875007
  6. Haug JB, Berild D, Blomberg B, Bruun JN, Flaatten HK, Leiva RA, Skrede S, Torfoss D, Undseth Ø (2013)
    [Aminoglycosides in severe sepsis]
    Tidsskr Nor Laegeforen, 133 (15), 1553-4
    DOI 10.4045/tidsskr.13.0866, PubMed 23970249
  7. Haug JB, Reikvam Å (2013)
    WHO defined daily doses versus hospital-adjusted defined daily doses: impact on results of antibiotic use surveillance
    J Antimicrob Chemother, 68 (12), 2940-7
    DOI 10.1093/jac/dkt268, PubMed 23838948
  8. Haugaard AK, Lund TT, Birch C, Rönsholt F, Trøseid M, Ullum H, Gerstoft J, Johansson PI, Nielsen SD, Ostrowski SR (2013)
    Discrepant coagulation profile in HIV infection: elevated D-dimer but impaired platelet aggregation and clot initiation
    AIDS, 27 (17), 2749-58
    DOI 10.1097/01.aids.0000432462.21723.ed, PubMed 23842126
  9. Hegertun IE, Sulheim Gundersen KM, Kleppa E, Zulu SG, Gundersen SG, Taylor M, Kvalsvig JD, Kjetland EF (2013)
    S. haematobium as a common cause of genital morbidity in girls: a cross-sectional study of children in South Africa
    PLoS Negl Trop Dis, 7 (3), e2104
    DOI 10.1371/journal.pntd.0002104, PubMed 23556009
  10. Jensenius M, Han PV, Schlagenhauf P, Schwartz E, Parola P, Castelli F, von Sonnenburg F, Loutan L, Leder K, Freedman DO, GeoSentinel Surveillance Network (2013)
    Acute and potentially life-threatening tropical diseases in western travelers--a GeoSentinel multicenter study, 1996-2011
    Am J Trop Med Hyg, 88 (2), 397-404
    DOI 10.4269/ajtmh.12-0551, PubMed 23324216
  11. Jourdan PM, Randrianasolo BS, Feldmeier H, Chitsulo L, Ravoniarimbinina P, Roald B, Kjetland EF (2013)
    Pathologic mucosal blood vessels in active female genital schistosomiasis: new aspects of a neglected tropical disease
    Int J Gynecol Pathol, 32 (1), 137-40
    DOI 10.1097/PGP.0b013e31824fe327, PubMed 23202777
  12. Landskron J, Taskén K (2013)
    CD147 in regulatory T cells
    Cell Immunol, 282 (1), 17-20
    DOI 10.1016/j.cellimm.2013.04.008, PubMed 23665204
  13. Lind A, Brekke K, Sommerfelt M, Holmberg JO, Aass HC, Baksaas I, Sørensen B, Dyrhol-Riise AM, Kvale D (2013)
    Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
    Vaccine, 31 (41), 4611-8
    DOI 10.1016/j.vaccine.2013.07.037, PubMed 23906886
  14. Lone AM, Taskén K (2013)
    Proinflammatory and immunoregulatory roles of eicosanoids in T cells
    Front Immunol, 4, 130
    DOI 10.3389/fimmu.2013.00130, PubMed 23760108
  15. MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BA, Jonsrud K, Lundgren B, Mellegard H, Moller-Stray J, Ronning K, Vestrheim DF, Vold L (2013)
    Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013
    Eurosurveillance, 18 (45), 2-5
  16. MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BÅ, Jonsrud K, Lundgren B, Mellegård H, Møller-Stray J, Rønning K, Vestrheim DF, Vold L (2013)
    Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013
    Euro Surveill, 18 (45), 20630
    DOI 10.2807/1560-7917.es2013.18.45.20630, PubMed 24229788
  17. Madec Y, Boufassa F, Porter K, Prins M, Sabin C, d'Arminio Monforte A, Amornkul P, Bartmeyer B, Sannes M, Venet A, Lambotte O, Meyer L, CASCADE Collaboration in Eurocoord (2013)
    Natural history of HIV-control since seroconversion
    AIDS, 27 (15), 2451-60
    DOI 10.1097/01.aids.0000431945.72365.01, PubMed 23912979
  18. Manner IW, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen SD, Nowak P, Os I, Trøseid M (2013)
    Markers of microbial translocation predict hypertension in HIV-infected individuals
    HIV Med, 14 (6), 354-61
    DOI 10.1111/hiv.12015, PubMed 23332095
  19. Ndeffo Mbah ML, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, Meyers LA, Townsend JP, Galvani AP (2013)
    Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa
    Proc Natl Acad Sci U S A, 110 (19), 7952-7
    DOI 10.1073/pnas.1221396110, PubMed 23589884
  20. Pedersen KK, Pedersen M, Trøseid M, Gaardbo JC, Lund TT, Thomsen C, Gerstoft J, Kvale D, Nielsen SD (2013)
    Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction
    J Acquir Immune Defic Syndr, 64 (5), 425-33
    DOI 10.1097/QAI.0b013e31829f919d, PubMed 23797689
  21. Rogne M, Taskén K (2013)
    Cell signalling analyses in the functional genomics era
    N Biotechnol, 30 (3), 333-8
    DOI 10.1016/j.nbt.2013.01.003, PubMed 23369868
  22. Singh M, Singh P, Vaira D, Torheim EA, Rahmouni S, Taskén K, Moutschen M (2013)
    The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice
    Eur J Clin Invest, 44 (2), 146-52
    DOI 10.1111/eci.12200, PubMed 24283208
  23. Størvold GL, Landskron J, Strozynski M, Arntzen MØ, Koehler CJ, Kalland ME, Taskén K, Thiede B (2013)
    Quantitative profiling of tyrosine phosphorylation revealed changes in the activity of the T cell receptor signaling pathway upon cisplatin-induced apoptosis
    J Proteomics, 91, 344-57
    DOI 10.1016/j.jprot.2013.07.019, PubMed 23933134
  24. Trøseid M, Nestvold TK, Rudi K, Thoresen H, Nielsen EW, Lappegård KT (2013)
    Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery
    Diabetes Care, 36 (11), 3627-32
    DOI 10.2337/dc13-0451, PubMed 23835694
  25. Undseth Ø, Gerlyng P, Goplen AK, Holter ES, von der Lippe E, Dunlop O (2013)
    Primary toxoplasmosis with critical illness and multi-organ failure in an immunocompetent young man
    Scand J Infect Dis, 46 (1), 58-62
    DOI 10.3109/00365548.2013.813065, PubMed 23902584
  26. Ushakova A, Pettersen FO, Mæland A, Lindqvist BH, Kvale D (2013)
    Bayesian estimation of HIV-1 dynamics in vivo
    Math Med Biol, 32 (1), 38-55
    DOI 10.1093/imammb/dqt018, PubMed 24078026
  27. Vang T, Landskron J, Viken MK, Oberprieler N, Torgersen KM, Mustelin T, Tasken K, Tautz L, Rickert RC, Lie BA (2013)
    The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses
    Hum Immunol, 74 (5), 574-85
    DOI 10.1016/j.humimm.2012.12.017, PubMed 23333624
  28. Wichmann D, Poppert S, Von Thien H, Clerinx J, Dieckmann S, Jensenius M, Parola P, Richter J, Schunk M, Stich A, Zanger P, Burchard GD, Tannich E (2013)
    Prospective European-wide multicentre study on a blood based real-time PCR for the diagnosis of acute schistosomiasis
    BMC Infect Dis, 13, 55
    DOI 10.1186/1471-2334-13-55, PubMed 23363565

Publications 2012

  1. Aldrin M, Raastad R, Tvete IF, Berild D, Frigessi A, Leegaard T, Monnet DL, Walberg M, Müller F (2012)
    Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment
    Stat Med, 32 (8), 1407-18
    DOI 10.1002/sim.5636, PubMed 23027651
  2. Brantsæter AB (2012)
    [Malaria treatment--herbal therapy in new clothes]
    Tidsskr Nor Laegeforen, 132 (6), 614
    DOI 10.4045/tidsskr.12.0238, PubMed 22456126
  3. Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D (2012)
    Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
    Int J Infect Dis, 16 (12), e879-85
    DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419
  4. Bugge HF, Karlsen NC, Oydna E, Rake MM, Wexels N, Bendabenda J, Roald B, Heier HE, Chisuwo L, Jourdan PM (2012)
    A study of blood transfusion services at a district hospital in Malawi
    Vox Sang, 104 (1), 37-45
    DOI 10.1111/j.1423-0410.2012.01628.x, PubMed 22765350
  5. Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
    Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
    J Acquir Immune Defic Syndr, 59 (2), e24-5
    DOI 10.1097/QAI.0b013e31823f35a7, PubMed 22245717
  6. Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
    Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
    Clin Exp Immunol, 167 (3), 492-8
    DOI 10.1111/j.1365-2249.2011.04524.x, PubMed 22288592
  7. De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G, European Network for Highly Infectious Diseases Working Group (2012)
    Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries
    Infect Control Hosp Epidemiol, 33 (10), 1008-16
    DOI 10.1086/667729, PubMed 22961020
  8. Gautret P, Cramer JP, Field V, Caumes E, Jensenius M, Gkrania-Klotsas E, de Vries PJ, Grobusch MP, Lopez-Velez R, Castelli F, Schlagenhauf P, Askling HH, von Sonnenburg F, Lalloo DG, Loutan L, Rapp C, Basto F, O'Connor FS, Weld L, Parola P, EuroTravNet Network (2012)
    Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010
    Eurosurveillance, 17 (26), 20205-26
  9. Gautret P, Cramer JP, Field V, Caumes E, Jensenius M, Gkrania-Klotsas E, de Vries PJ, Grobusch MP, Lopez-Velez R, Castelli F, Schlagenhauf P, Hervius Askling H, von Sonnenburg F, Lalloo DG, Loutan L, Rapp C, Basto F, Santos O'Connor F, Weld L, Parola P, EuroTravNet Network (2012)
    Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010
    Euro Surveill, 17 (26)
    PubMed 22790534
  10. Kalland ME, Solheim SA, Skånland SS, Taskén K, Berge T (2012)
    Modulation of proximal signaling in normal and transformed B cells by transmembrane adapter Cbp/PAG
    Exp Cell Res, 318 (14), 1611-9
    DOI 10.1016/j.yexcr.2012.05.014, PubMed 22659621
  11. Kjetland EF, Leutscher PD, Ndhlovu PD (2012)
    A review of female genital schistosomiasis
    Trends Parasitol, 28 (2), 58-65
    DOI 10.1016/j.pt.2011.10.008, PubMed 22245065
  12. Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D (2012)
    Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
    Scand J Infect Dis, 44 (8), 566-72
    DOI 10.3109/00365548.2011.653581, PubMed 22339485
  13. Lodi S, Meyer L, Kelleher AD, Rosinska M, Ghosn J, Sannes M, Porter K (2012)
    Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
    Arch Intern Med, 172 (16), 1252-5
    DOI 10.1001/archinternmed.2012.2719, PubMed 22826124
  14. Manner IW, Baekken M, Oektedalen O, Os I (2012)
    Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
    Blood Press, 21 (5), 311-9
    DOI 10.3109/08037051.2012.680742, PubMed 22564000
  15. Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I (2012)
    Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
    J Clin Hypertens (Greenwich), 15 (2), 101-6
    DOI 10.1111/jch.12029, PubMed 23339727
  16. Nowak P, Abdurahman S, Lindkvist A, Troseid M, Sönnerborg A (2012)
    Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
    Int J Microbiol, 2012, 263836
    DOI 10.1155/2012/263836, PubMed 22719767
  17. Nowak P, Nystrom J, Troseid M (2012)
    High levels of HMGB1 in plasma may be due to ex vivo cell necrosis
    Anticancer Res, 32 (9), 4067-9
    PubMed 22993362
  18. Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
    Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
    Arterioscler Thromb Vasc Biol, 33 (2), e47-55
    DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017
  19. Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V (2012)
    Infectious encephalitis: a description of a Norwegian cohort
    Scand J Infect Dis, 45 (3), 179-85
    DOI 10.3109/00365548.2012.719634, PubMed 23113672
  20. Rekić D, Röshammar D, Bergstrand M, Tarning J, Calcagno A, D'Avolio A, Ormaasen V, Vigan M, Barrail-Tran A, Ashton M, Gisslén M, Äbelö A (2012)
    External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
    AAPS J, 15 (2), 308-15
    DOI 10.1208/s12248-012-9440-8, PubMed 23224752
  21. Scott JD, Dessauer CW, Taskén K (2012)
    Creating order from chaos: cellular regulation by kinase anchoring
    Annu Rev Pharmacol Toxicol, 53, 187-210
    DOI 10.1146/annurev-pharmtox-011112-140204, PubMed 23043438
  22. Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
    Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
    Innate Immun, 19 (3), 290-7
    DOI 10.1177/1753425912461042, PubMed 23070967
  23. Wessman M, Westling K, Aho I, Quist-Paulsen E, Wæhre T, Rolfhamre L, Weis N, Katzenstein TL (2012)
    Major differences in assisted reproductive treatments offered to HIV-1 infected patients in the Nordic countries
    Scand J Infect Dis, 44 (5), 402-4
    DOI 10.3109/00365548.2011.649491, PubMed 22292615

Publications 2011

  1. Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
    Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
    J Infect, 63 (4), 308-16
    DOI 10.1016/j.jinf.2011.07.004, PubMed 21781987
  2. Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
    Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
    BMC Infect Dis, 11, 75
    DOI 10.1186/1471-2334-11-75, PubMed 21435254
  3. Brantsæter AB (2011)
    [Did vaccines and hygiene recommendations affect the pandemic?]
    Tidsskr Nor Laegeforen, 131 (7), 662
    DOI 10.4045/tidsskr.11.0318, PubMed 21494288
  4. Corthay A, Lorvik KB, Bogen B (2011)
    Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer
    Scand J Immunol, 73 (6), 527-30
    DOI 10.1111/j.1365-3083.2011.02558.x, PubMed 21388431
  5. Fagan M, Mæhlen M, Lindbæk M, Berild D (2011)
    Antibiotic prescribing in nursing homes in an area with low prevalence of antibiotic resistance: compliance with national guidelines
    Scand J Prim Health Care, 30 (1), 10-5
    DOI 10.3109/02813432.2011.629156, PubMed 22188479
  6. Haug JB, Berild D, Walberg M, Reikvam A (2011)
    Increased antibiotic use in Norwegian hospitals despite a low antibiotic resistance rate
    J Antimicrob Chemother, 66 (11), 2643-6
    DOI 10.1093/jac/dkr361, PubMed 21903657
  7. Haug JB, Myhr R, Reikvam A (2011)
    Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals
    BMC Med Res Methodol, 11, 166
    DOI 10.1186/1471-2288-11-166, PubMed 22166018
  8. Hesstvedt L, Wilhelmsen M, Mengshoel AT, Dyrhol-Riise AM (2011)
    Two Norwegian patients with melioidosis presenting with bacteraemia and splenic and prostatic abscesses
    J Travel Med, 18 (6), 418-21
    DOI 10.1111/j.1708-8305.2011.00550.x, PubMed 22017720
  9. Johannessen A (2011)
    Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital-author's response
    J. Antimicrob. Chemother., 66 (4), 957-958
  10. Johannessen A (2011)
    Are men the losers of the antiretroviral treatment scale-up?
    AIDS, 25 (9), 1225-6
    DOI 10.1097/QAD.0b013e32834403b8, PubMed 21593620
  11. Johannessen A, Naman E, Gundersen SG, Bruun JN (2011)
    Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania
    BMC Infect Dis, 11, 190
    DOI 10.1186/1471-2334-11-190, PubMed 21745396
  12. Jourdan PM, Holmen SD, Gundersen SG, Roald B, Kjetland EF (2011)
    HIV target cells in Schistosoma haematobium-infected female genital mucosa
    Am J Trop Med Hyg, 85 (6), 1060-4
    DOI 10.4269/ajtmh.2011.11-0135, PubMed 22144444
  13. Jourdan PM, Roald B, Poggensee G, Gundersen SG, Kjetland EF (2011)
    Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection
    PLoS Negl Trop Dis, 5 (6), e1170
    DOI 10.1371/journal.pntd.0001170, PubMed 21666790
  14. Kivuyo SL, Johannessen A, Trøseid M, Kasubi MJ, Gundersen SG, Naman E, Mushi D, Ngowi BJ, Mfinanga GS, Bruun JN (2011)
    p24 antigen detection on dried blood spots is a feasible and reliable test for infant HIV infection in rural Tanzania
    Int J STD AIDS, 22 (12), 719-21
    DOI 10.1258/ijsa.2009.009382, PubMed 22174052
  15. Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2011)
    Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
    APMIS, 120 (3), 204-9
    DOI 10.1111/j.1600-0463.2011.02843.x, PubMed 22339677
  16. Odolini S, Parola P, Gkrania-Klotsas E, Caumes E, Schlagenhauf P, López-Vélez R, Burchard GD, Santos-O'Connor F, Weld L, von Sonnenburg F, Field V, de Vries P, Jensenius M, Loutan L, Castelli F (2011)
    Travel-related imported infections in Europe, EuroTravNet 2009
    Clin Microbiol Infect, 18 (5), 468-74
    DOI 10.1111/j.1469-0691.2011.03596.x, PubMed 21848975
  17. Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
    An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
    J Virol, 85 (13), 6557-66
    DOI 10.1128/JVI.00073-11, PubMed 21490090
  18. Rekić D, Clewe O, Röshammar D, Flamholc L, Sönnerborg A, Ormaasen V, Gisslén M, Abelö A, Ashton M (2011)
    Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy
    AAPS J, 13 (4), 598-605
    DOI 10.1208/s12248-011-9299-0, PubMed 21913053
  19. Röshammar D, Simonsson US, Ekvall H, Flamholc L, Ormaasen V, Vesterbacka J, Wallmark E, Ashton M, Gisslén M (2011)
    Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients
    J Pharmacokinet Pharmacodyn, 38 (6), 727-42
    DOI 10.1007/s10928-011-9217-1, PubMed 21964996
  20. Torfoss D, Høiby EA, Holte H, Kvaløy S (2011)
    The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review
    Acta Oncol, 51 (4), 433-40
    DOI 10.3109/0284186X.2011.633931, PubMed 22175253
  21. Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
    The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
    Scand J Immunol, 74 (6), 632-9
    DOI 10.1111/j.1365-3083.2011.02618.x, PubMed 21883353
  22. Trøseid M (2011)
    [The fight against HIV--two scenarios]
    Tidsskr Nor Laegeforen, 131 (23), 2331
    DOI 10.4045/tidsskr.11.1213, PubMed 22139097
  23. Trøseid M, Sönnerborg A, Nowak P (2011)
    High mobility group box protein-1 in HIV-1 infection
    Curr HIV Res, 9 (1), 6-10
    DOI 10.2174/157016211794582632, PubMed 21198433
  24. van der Helm JJ, Prins M, del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill J, Hamouda O, Sannes M, Porter K, Geskus RB, CASCADE Collaboration (2011)
    The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007
    AIDS, 25 (8), 1083-91
    DOI 10.1097/QAD.0b013e3283471cce, PubMed 21537114

Publications 2010

  1. Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
    Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
    J Acquir Immune Defic Syndr, 53 (3), 419-20
    DOI 10.1097/QAI.0b013e3181ba4101, PubMed 20190590
  2. Behrens RH, Carroll B, Hellgren U, Visser LG, Siikamäki H, Vestergaard LS, Calleri G, Jänisch T, Myrvang B, Gascon J, Hatz C (2010)
    The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator?
    Malar J, 9, 266
    DOI 10.1186/1475-2875-9-266, PubMed 20920352
  3. Berild D, Lindbaek M (2010)
    Use of antibiotics gives cause for concern
    Tidsskr Nor Laegeforen, 130 (20), 2010
    DOI 10.4045/tidsskr.10.0981, PubMed 20967030
  4. Brandsaeter B, Sabel M, Rui TO (2010)
    [A woman with known anxiety, depression and alcohol abuse]
    Tidsskr Nor Laegeforen, 130 (4), 385-6
    DOI 10.4045/tidsskr.09.0464, PubMed 20220864
  5. Bratholm C, Johannessen A, Naman E, Gundersen SG, Kivuyo SL, Holberg-Petersen M, Ormaasen V, Bruun JN (2010)
    Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital
    J Antimicrob Chemother, 65 (9), 1996-2000
    DOI 10.1093/jac/dkq234, PubMed 20576637
  6. Edén A, Andersson LM, Andersson O, Flamholc L, Josephson F, Nilsson S, Ormaasen V, Svedhem V, Säll C, Sönnerborg A, Tunbäck P, Gisslén M (2010)
    Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients
    AIDS Res Hum Retroviruses, 26 (5), 533-40
    DOI 10.1089/aid.2009.0177, PubMed 20455766
  7. Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, Castelli F, Gkrania-Klotsas E, Weld L, Lopez-Velez R, de Vries P, von Sonnenburg F, Loutan L, Parola P, EuroTravNet network (2010)
    Travel and migration associated infectious diseases morbidity in Europe, 2008
    BMC Infect Dis, 10, 330
    DOI 10.1186/1471-2334-10-330, PubMed 21083874
  8. Grydeland H, Walhovd KB, Westlye LT, Due-Tønnessen P, Ormaasen V, Sundseth Ø, Fjell AM (2010)
    Amnesia following herpes simplex encephalitis: diffusion-tensor imaging uncovers reduced integrity of normal-appearing white matter
    Radiology, 257 (3), 774-81
    DOI 10.1148/radiol.10100179, PubMed 20935078
  9. Haug JB, Raastad R, Berild D (2010)
    ["Look to Norway"--but for how long?]
    Tidsskr Nor Laegeforen, 130 (15), 1484-6
    DOI 10.4045/tidsskr.10.0356, PubMed 20706311
  10. Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
    [Syphilis and blood transfusion]
    Tidsskr Nor Laegeforen, 130 (8), 839-41
    DOI 10.4045/tidsskr.08.0188, PubMed 20418930
  11. Johannessen A (2010)
    Dried blood spots in HIV monitoring: applications in resource-limited settings
    Bioanalysis, 2 (11), 1893-908
    DOI 10.4155/bio.10.120, PubMed 21083497
  12. Johannessen A (2010)
    Quantification of HIV-1 RNA on dried blood spots
    AIDS, 24 (3), 475-6
    DOI 10.1097/QAD.0b013e3283365383, PubMed 20087079
  13. Johannessen A, Garrido C, Zahonero N, Naman E, de Mendoza C (2010)
    HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System
    J Antimicrob Chemother, 66 (2), 260-4
    DOI 10.1093/jac/dkq433, PubMed 21115444
  14. Johannessen A, Holberg-Petersen M, Lövgaarden G, Naman E, Ormaasen V, Matee MI, Gundersen SG, Bruun JN (2010)
    HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania
    Antivir Ther, 15 (7), 1003-9
    DOI 10.3851/IMP1660, PubMed 21041915
  15. Kjetland EF, Kurewa EN, Mduluza T, Midzi N, Gomo E, Friis H, Gundersen SG, Ndhlovu PD (2010)
    The first community-based report on the effect of genital Schistosoma haematobium infection on female fertility
    Fertil Steril, 94 (4), 1551-3
    DOI 10.1016/j.fertnstert.2009.12.050, PubMed 20149365
  16. Kjetland EF, Ndhlovu PD, Mduluza T, Deschoolmeester V, Midzi N, Gomo E, Gwanzura L, Mason PR, Vermorken JB, Friis H, Gundersen SG, Baay MF (2010)
    The effects of genital schistosoma haematobium on human papillomavirus and the development of cervical neoplasia after five years in a Zimbabwean population
    Eur J Gynaecol Oncol, 31 (2), 169-73
    PubMed 20527233
  17. Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D (2010)
    Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
    AIDS, 24 (17), 2609-18
    DOI 10.1097/QAD.0b013e32833e502b, PubMed 20935558
  18. Manner IW, Baekken M, Oektedalen O, Sandvik L, Os I (2010)
    Effect of HIV duration on ambulatory blood pressure in HIV-infected individuals with high office blood pressure
    Blood Press, 19 (3), 188-95
    DOI 10.3109/08037051.2010.483055, PubMed 20482442
  19. Mendelson M, Davis XM, Jensenius M, Keystone JS, von Sonnenburg F, Hale DC, Burchard GD, Field V, Vincent P, Freedman DO, GeoSentinel Surveillance Network (2010)
    Health risks in travelers to South Africa: the GeoSentinel experience and implications for the 2010 FIFA World Cup
    Am J Trop Med Hyg, 82 (6), 991-5
    DOI 10.4269/ajtmh.2010.10-0198, PubMed 20519590
  20. Myrvang B (2010)
    [A fifth plasmodium that can cause malaria]
    Tidsskr Nor Laegeforen, 130 (3), 282-3
    DOI 10.4045/tidsskr.09.0554, PubMed 20160773
  21. Pettersen FO, Taskén K, Kvale D (2010)
    Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection
    Clin Exp Immunol, 161 (2), 315-23
    DOI 10.1111/j.1365-2249.2010.04179.x, PubMed 20491784
  22. Storla DG, Yimer S, Bjune GA (2010)
    Can treatment delay be utilized as a key variable for monitoring the pool of infectious tuberculosis in a population?
    J Infect Dev Ctries, 4 (2), 83-90
    DOI 10.3855/jidc.211, PubMed 20212338
  23. Trøseid M, Johannessen A (2010)
    [The battle against HIV can be won, but there is not enough money!]
    Tidsskr Nor Laegeforen, 130 (16), 1599-600
    DOI 10.4045/tidsskr.10.0705, PubMed 20805855
  24. Trøseid M, Johannessen A (2010)
    [A step in the right direction]
    Tidsskr Nor Laegeforen, 130 (22), 2223
    DOI 10.4045/tidsskr.10.1100, PubMed 21109841
  25. Trøseid M, Nowak P, Nyström J, Lindkvist A, Abdurahman S, Sönnerborg A (2010)
    Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy
    AIDS, 24 (11), 1733-7
    DOI 10.1097/QAD.0b013e32833b254d, PubMed 20502315
  26. Weiss TW, Schumacher S, Kaun C, Katsaros KM, Trøseid M, Huber K, Maurer G, Wojta J (2010)
    Association between smoking and presence of mycoplasma pneumoniae in circulating leukocytes
    Swiss Med Wkly, 140, w13105
    DOI 10.4414/smw.2010.13105, PubMed 20927683

Publications 2009

  1. Berhe N, Myrvang B, Gundersen SG (2009)
    Gastro-intestinal symptoms associated with intense Schistosoma mansoni infection affect class-attentiveness of schoolchildren in Ethiopia
    Acta Trop, 110 (1), 52-6
    DOI 10.1016/j.actatropica.2009.01.007, PubMed 19283896
  2. Brantsaeter AB (2009)
    [An underestimated throat bacteria]
    Tidsskr Nor Laegeforen, 129 (17), 1756
    DOI 10.4045/tidsskr.09.0788, PubMed 19756058
  3. Brantsaeter AB, Romanus V, Andersen PH, Heldal E (2009)
    Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries
    Int J Tuberc Lung Dis, 13 (4), 440-5
    PubMed 19335948
  4. Corthay A, Lundin KU, Lorvik KB, Hofgaard PO, Bogen B (2009)
    Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells
    Cancer Res, 69 (14), 5901-7
    DOI 10.1158/0008-5472.CAN-08-4816, PubMed 19567679
  5. Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte Ad, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD, EuroSIDA Study Group (2009)
    Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings
    J Infect Dis, 200 (5), 687-97
    DOI 10.1086/604731, PubMed 19604043
  6. Dalgard O, Mangia A (2009)
    Management of patients with hepatitis C virus genotype 2 or 3: comments on updated American Association for the Study of Liver Diseases practice guidelines
    Hepatology, 50 (1), 323; author reply 324-5
    DOI 10.1002/hep.23038, PubMed 19554545
  7. Ellertsen LK, Storla DG, Diep LM, Brokstad KA, Wiker HG, Hetland G (2009)
    Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy
    BMC Infect Dis, 9, 100
    DOI 10.1186/1471-2334-9-100, PubMed 19558655
  8. Gautret P, Clerinx J, Caumes E, Simon F, Jensenius M, Loutan L, Schlagenhauf P, Castelli F, Freedman D, Miller A, Bronner U, Parola P (2009)
    Imported human African trypanosomiasis in Europe, 2005-2009
    Euro Surveill, 14 (36)
    PubMed 19758542
  9. Hauge SH, Dudman SG, Borgen K, Hungnes O, Brantsaeter A, Iversen B, Aavitsland P (2009)
    [Disease caused by the new influenza A(H1N1) virus]
    Tidsskr Nor Laegeforen, 129 (17), 1736-9
    DOI 10.4045/tidsskr.09.0748, PubMed 19756053
  10. Hotez PJ, Fenwick A, Kjetland EF (2009)
    Africa's 32 cents solution for HIV/AIDS
    PLoS Negl Trop Dis, 3 (5), e430
    DOI 10.1371/journal.pntd.0000430, PubMed 19479041
  11. Jensenius M, Davis X, von Sonnenburg F, Schwartz E, Keystone JS, Leder K, Lopéz-Véléz R, Caumes E, Cramer JP, Chen L, Parola P, GeoSentinel Surveillance Network (2009)
    Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008
    Emerg Infect Dis, 15 (11), 1791-8
    DOI 10.3201/eid1511.090677, PubMed 19891867
  12. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, Kasubi MJ, Gundersen SG, Bruun JN, de Mendoza C (2009)
    Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania
    Clin Infect Dis, 49 (6), 976-81
    DOI 10.1086/605502, PubMed 19663598
  13. Johannessen A, Naman E, Kivuyo SL, Kasubi MJ, Holberg-Petersen M, Matee MI, Gundersen SG, Bruun JN (2009)
    Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania
    BMC Infect Dis, 9, 108
    DOI 10.1186/1471-2334-9-108, PubMed 19583845
  14. Johannessen A, Trøseid M, Calmy A (2009)
    Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings
    J Antimicrob Chemother, 64 (6), 1126-9
    DOI 10.1093/jac/dkp353, PubMed 19776036
  15. Josephson F, Andersson MC, Flamholc L, Gisslén M, Hagberg L, Ormaasen V, Sönnerborg A, Vesterbacka J, Böttiger Y (2009)
    The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
    Eur J Clin Pharmacol, 66 (4), 349-57
    DOI 10.1007/s00228-009-0763-z, PubMed 19967342
  16. Kjetland EF, Hove RJ, Gomo E, Midzi N, Gwanzura L, Mason P, Friis H, Verweij JJ, Gundersen SG, Ndhlovu PD, Mduluza T, Van Lieshout L (2009)
    Schistosomiasis PCR in vaginal lavage as an indicator of genital Schistosoma haematobium infection in rural Zimbabwean women
    Am J Trop Med Hyg, 81 (6), 1050-5
    DOI 10.4269/ajtmh.2009.09-0081, PubMed 19996436
  17. Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
    Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
    J Clin Microbiol, 47 (7), 2170-4
    DOI 10.1128/JCM.00519-09, PubMed 19420166
  18. Lillerud LE, Stuestoel VM, Hoel RE, Rukeba Z, Kjetland EF (2009)
    Exploring the feasibility and possible efficacy of mass treatment and education of young females as schistosomiasis influences the HIV epidemic
    Arch Gynecol Obstet, 281 (3), 455-60
    DOI 10.1007/s00404-009-1108-y, PubMed 19434416
  19. Maagaard A, Kvale D (2009)
    Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
    J Antimicrob Chemother, 64 (5), 901-9
    DOI 10.1093/jac/dkp316, PubMed 19740910
  20. Maagaard A, Kvale D (2009)
    Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity
    Scand J Infect Dis, 41 (11-12), 808-17
    DOI 10.3109/00365540903186181, PubMed 19922062
  21. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O (2009)
    Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania
    BMC Infect Dis, 9, 1
    DOI 10.1186/1471-2334-9-1, PubMed 19144106
  22. Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman I, Horban A, Korn K, Kücherer C, Leitner T et al. (2009)
    Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
    Retrovirology, 6, 49
    DOI 10.1186/1742-4690-6-49, PubMed 19457244
  23. Sandanger Ø, Ryan L, Bohnhorst J, Iversen AC, Husebye H, Halaas Ø, Landrø L, Aukrust P, Frøland SS, Elson G, Visintin A, Øktedalen O, Damås JK, Sundan A, Golenbock D, Espevik T (2009)
    IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients
    J Immunol, 182 (1), 588-95
    DOI 10.4049/jimmunol.182.1.588, PubMed 19109192
  24. Skeie L, Bugge H, Negaard A, Bergersen BM (2009)
    Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study
    HIV Med, 11 (3), 170-7
    DOI 10.1111/j.1468-1293.2009.00761.x, PubMed 19780861
  25. Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM (2009)
    Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population
    Eur J Immunol, 39 (5), 1280-7
    DOI 10.1002/eji.200839002, PubMed 19384871

Publications 2008

  1. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
    Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population
    Nephrol Dial Transplant, 23 (10), 3130-7
    DOI 10.1093/ndt/gfn236, PubMed 18469311
  2. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
    Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy
    J Hypertens, 26 (11), 2126-33
    DOI 10.1097/HJH.0b013e32830ef5fb, PubMed 18854751
  3. Baekken M, Os I, Stenehjem A, Sandvik L, Oektedalen O (2008)
    Association between HIV infection and attenuated diurnal blood pressure rhythm in untreated hypertensive individuals
    HIV Med, 10 (1), 44-52
    DOI 10.1111/j.1468-1293.2008.00655.x, PubMed 19018875
  4. Berhe N, Myrvang B, Gundersen SG (2008)
    Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia
    Am J Trop Med Hyg, 78 (2), 228-34
    DOI 10.4269/ajtmh.2008.78.228, PubMed 18256420
  5. Berild D, Abrahamsen TG, Andresen S, Bjørløw E, Haug O, Kossenko IM, Kubar OI, Lelek M, Mintchenko SI, Pyasetskaya MF, Ringertz SH, Sysenko GA (2008)
    A controlled intervention study to improve antibiotic use in a Russian paediatric hospital
    Int J Antimicrob Agents, 31 (5), 478-83
    DOI 10.1016/j.ijantimicag.2008.01.009, PubMed 18343641
  6. Berild D, Haug JB (2008)
    [Rational use of antibiotics in hospitals]
    Tidsskr Nor Laegeforen, 128 (20), 2335-9
    PubMed 19096490
  7. Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K, CASCADE Collaboration (2008)
    Changes in the risk of death after HIV seroconversion compared with mortality in the general population
    JAMA, 300 (1), 51-9
    DOI 10.1001/jama.300.1.51, PubMed 18594040
  8. Bjark P, Ormaasen V, Skjelmerud T (2008)
    [Treatment of erythema migrans]
    Tidsskr Nor Laegeforen, 128 (24), 2844
    PubMed 19092956
  9. Brantsaeter AB (2008)
    [Action against tuberculosis--all has its time]
    Tidsskr Nor Laegeforen, 128 (24), 2817
    PubMed 19092946
  10. Cazorla C, Socolovschi C, Jensenius M, Parola P (2008)
    Tick-borne diseases: tick-borne spotted fever rickettsioses in Africa
    Infect Dis Clin North Am, 22 (3), 531-44, ix-x
    DOI 10.1016/j.idc.2008.03.009, PubMed 18755389
  11. Dalgard O, Bjøro K, Ring-Larsen H, Bjornsson E, Holberg-Petersen M, Skovlund E, Reichard O, Myrvang B, Sundelöf B, Ritland S, Hellum K, Frydén A, Florholmen J, Verbaan H, North-C Group (2008)
    Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
    Hepatology, 47 (1), 35-42
    DOI 10.1002/hep.21975, PubMed 17975791
  12. Damås JK, Davì G, Jensenius M, Santilli F, Otterdal K, Ueland T, Flo TH, Lien E, Espevik T, Frøland SS, Vitale G, Raoult D, Aukrust P (2008)
    Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever
    J Infect, 58 (1), 68-75
    DOI 10.1016/j.jinf.2008.11.008, PubMed 19091423
  13. Eliassen KE, Fetveit A, Hjortdahl P, Berild D, Lindbaek M (2008)
    [New guidelines for antibiotic use in primary health care]
    Tidsskr Nor Laegeforen, 128 (20), 2330-4
    PubMed 19096489
  14. Eliassen KE, Lindbaek M, Berild D, Hjortdahl P, Fetveit A (2008)
    [First-choice treatment for erythema migrans is still penicillin]
    Tidsskr Nor Laegeforen, 128 (15), 1681; author reply 1681
    PubMed 18704139
  15. Haldorsen IS, Kråkenes J, Goplen AK, Dunlop O, Mella O, Espeland A (2008)
    AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003
    BMC Cancer, 8, 225
    DOI 10.1186/1471-2407-8-225, PubMed 18684320
  16. Holm M, Pettersen FO, Kvale D (2008)
    PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples
    Curr HIV Res, 6 (1), 49-58
    PubMed 18288975
  17. Jelinek T, Schade Larsen C, Siikamäki H, Myrvang B, Chiodini P, Gascon J, Visser L, Kapaun A, Just-Nübling G (2008)
    European cluster of imported falciparum malaria from Gambia
    Euro Surveill, 13 (51)
    PubMed 19094917
  18. Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, Gundersen SG, Bruun JN (2008)
    Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania
    BMC Infect Dis, 8, 52
    DOI 10.1186/1471-2334-8-52, PubMed 18430196
  19. Josephson F, Bertilsson L, Böttiger Y, Flamholc L, Gisslén M, Ormaasen V, Sönnerborg A, Diczfalusy U (2008)
    CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels
    Eur J Clin Pharmacol, 64 (8), 775-81
    DOI 10.1007/s00228-008-0492-8, PubMed 18458892
  20. Jourdan PM, Laoussou P, Lybie A, Kjetland EF (2008)
    Indicators of anaemia in under-fives with malaria at a hospital in northern Cameroon
    West Afr J Med, 27 (1), 7-12
    PubMed 18689296
  21. Kjetland EF, Kurewa EN, Ndhlovu PD, Midzi N, Gwanzura L, Mason PR, Gomo E, Sandvik L, Mduluza T, Friis H, Gundersen SG (2008)
    Female genital schistosomiasis--a differential diagnosis to sexually transmitted disease: genital itch and vaginal discharge as indicators of genital Schistosoma haematobium morbidity in a cross-sectional study in endemic rural Zimbabwe
    Trop Med Int Health, 13 (12), 1509-17
    DOI 10.1111/j.1365-3156.2008.02161.x, PubMed 19055625
  22. Kjetland EF, Ndhlovu PD, Kurewa EN, Midzi N, Gomo E, Mduluza T, Friis H, Gundersen SG (2008)
    Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment
    Am J Trop Med Hyg, 79 (1), 79-83
    DOI 10.4269/ajtmh.2008.79.79, PubMed 18606767
  23. Magnus P, Brubakk O, Nyland H, Wold BH, Gjessing HK, Brandt I, Eidem T, Nøkleby H, Stene-Larsen G (2008)
    Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome
    Vaccine, 27 (1), 23-7
    DOI 10.1016/j.vaccine.2008.10.043, PubMed 18984023
  24. Mørch K, Strand Ø, Dunlop O, Berg A, Langeland N, Leiva RA, Longva JA, Sjursen H, Skrede S, Sundal J, Jensenius M (2008)
    Severe malaria and artesunate treatment, Norway
    Emerg Infect Dis, 14 (11), 1816-8
    DOI 10.3201/eid1411.080636, PubMed 18976584
  25. Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D (2008)
    Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment
    J Infect Dis, 198 (10), 1474-81
    DOI 10.1086/592713, PubMed 18851688
  26. Newport MJ, Myrvang B (2008)
    Proceedings of a joint meeting between the Norwegian Society of Infectious Diseases and the Royal Society of Tropical Medicine and Hygiene, Oslo, 20 June 2008
    Trans R Soc Trop Med Hyg, 103 (4), 321-4
    DOI 10.1016/j.trstmh.2008.11.010, PubMed 19111872
  27. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O (2008)
    Pulmonary tuberculosis among people living with HIV/AIDS attending care and treatment in rural northern Tanzania
    BMC Public Health, 8, 341
    DOI 10.1186/1471-2458-8-341, PubMed 18826574
  28. Torfoss D, Høiby EA, Holte H, Kvaløy S (2008)
    [Penicillin and aminoglycoside in febrile neutropenia]
    Tidsskr Nor Laegeforen, 128 (23), 2738-40
    PubMed 19079423

Publications 2007

  1. Behrens RH, Carroll B, Beran J, Bouchaud O, Hellgren U, Hatz C, Jelinek T, Legros F, Mühlberger N, Myrvang B, Siikamäki H, Visser L, TropNetEurop (2007)
    The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
    Malar J, 6, 114
    DOI 10.1186/1475-2875-6-114, PubMed 17716367
  2. Berhe N, Halvorsen BL, Gundersen TE, Myrvang B, Gundersen SG, Blomhoff R (2007)
    Reduced serum concentrations of retinol and alpha-tocopherol and high concentrations of hydroperoxides are associated with community levels of S. mansoni infection and schistosomal periportal fibrosis in Ethiopian school children
    Am J Trop Med Hyg, 76 (5), 943-9
    DOI 10.4269/ajtmh.2007.76.943, PubMed 17488920
  3. Berhe N, Myrvang B, Gundersen SG (2007)
    Intensity of Schistosoma mansoni, hepatitis B, age, and sex predict levels of hepatic periportal thickening/fibrosis (PPT/F): a large-scale community-based study in Ethiopia
    Am J Trop Med Hyg, 77 (6), 1079-86
    DOI 10.4269/ajtmh.2007.77.1079, PubMed 18165526
  4. Brantsaeter AB, Holberg-Petersen M, Jeansson S, Goplen AK, Bruun JN (2007)
    CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study
    BMC Infect Dis, 7, 127
    DOI 10.1186/1471-2334-7-127, PubMed 17986346
  5. Bugge H, Negaard A, Skeie L, Bergersen B (2007)
    Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients
    HIV Med, 8 (8), 475-82
    DOI 10.1111/j.1468-1293.2007.00494.x, PubMed 17944679
  6. Haukeland JW, Lorgen I, Schreiner LT, Frigstad SO, Brandsaeter B, Bjøro K, Bang C, Raknerud N, Konopski Z (2007)
    Incidence rates and causes of cirrhosis in a Norwegian population
    Scand J Gastroenterol, 42 (12), 1501-8
    DOI 10.1080/00365520701478014, PubMed 17852839
  7. Jensenius M, Berild D, Ormaasen V, Maehlen J, Lindegren G, Falk KI (2007)
    Fatal subarachnoidal haemorrhage in a Norwegian traveller with dengue virus infection
    Scand J Infect Dis, 39 (3), 272-4
    DOI 10.1080/00365540600891307, PubMed 17366065
  8. Jensenius M, Maeland A, Brubakk O (2007)
    Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics
    Travel Med Infect Dis, 6 (1-2), 45-7
    DOI 10.1016/j.tmaid.2007.09.043, PubMed 18342274
  9. Jensenius M, von der Lippe B, Hermansen NO, Jahr G, Caugant DA, Høiby EA, Vene S (2007)
    Brucellar mastitis: presentation of a case and review of the literature
    Int J Infect Dis, 12 (1), 98-100
    DOI 10.1016/j.ijid.2007.03.007, PubMed 17537662
  10. Kolstad A, Holte H, Fosså A, Lauritzsen GF, Gaustad P, Torfoss D (2007)
    Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen
    Haematologica, 92 (1), 139-40
    DOI 10.3324/haematol.10564, PubMed 17229653
  11. Krook AL, Stokka D, Heger B, Nygaard E (2007)
    Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study
    Eur Addict Res, 13 (4), 216-21
    DOI 10.1159/000104884, PubMed 17851243
  12. Mengistu Z, Engh V, Melby KK, von der Lippe E, Qvigstad E (2007)
    Postmenopausal vaginal bleeding caused by endometrial tuberculosis
    Acta Obstet Gynecol Scand, 86 (5), 631-2
    DOI 10.1080/00016340500543741, PubMed 17464596
  13. Maagaard A, Holberg-Petersen M, Torjesen PA, Bruun JN, Kvale D (2007)
    Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients
    HIV Clin Trials, 8 (5), 345-53
    DOI 10.1310/hct0805-345, PubMed 17956836
  14. Ormaasen V, Sandvik L, Dudman SG, Bruun JN (2007)
    HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population
    Scand J Infect Dis, 39 (1), 51-7
    DOI 10.1080/00365540600904779, PubMed 17366013
  15. Storla DG, Rahim Z, Islam MA, Plettner S, Begum V, Myrvang B, Bjune G, Rønnild E, Dahle UR, Mannsåker T (2007)
    Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh
    Scand J Infect Dis, 39 (2), 142-5
    DOI 10.1080/00365540600951242, PubMed 17366031
  16. Torfoss D, Høiby EA, Tangen JM, Holte H, Bø K, Meyer P, Grøttum K, Weyde K, Lauritzsen GF, Sandstad B, Jacobsen AB, Olsen H, Kvaløy S (2007)
    Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial
    J Antimicrob Chemother, 59 (4), 711-7
    DOI 10.1093/jac/dkm003, PubMed 17327294
  17. Zuckerman J, van Hattum J, Cafferkey M, Gjørup I, Hoel T, Rummukainen ML, Weiland O (2007)
    Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
    Lancet Infect Dis, 7 (6), 410-9
    DOI 10.1016/S1473-3099(07)70136-6, PubMed 17521594

Publications 2006

  1. Bergersen BM (2006)
    Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy
    Drugs, 66 (15), 1971-87
    DOI 10.2165/00003495-200666150-00006, PubMed 17100407
  2. Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
    Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
    Scand J Infect Dis, 38 (8), 682-9
    DOI 10.1080/00365540500361302, PubMed 16857615
  3. Berhe N, Geitung JT, Medhin G, Gundersen SG (2006)
    Large scale evaluation of WHO's ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia
    Trop Med Int Health, 11 (8), 1286-94
    DOI 10.1111/j.1365-3156.2006.01665.x, PubMed 16903891
  4. Brantsaeter AB (2006)
    [Tularemia]
    Tidsskr Nor Laegeforen, 126 (8), 1034
    PubMed 16619059
  5. Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V (2006)
    [HIV/AIDS--from lethal syndrome to chronic disease]
    Tidsskr Nor Laegeforen, 126 (23), 3121-4
    PubMed 17160119
  6. Damås JK, Jensenius M, Ueland T, Otterdal K, Yndestad A, Frøland SS, Rolain JM, Myrvang B, Raoult D, Aukrust P (2006)
    Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets
    J Immunol, 177 (4), 2699-706
    DOI 10.4049/jimmunol.177.4.2699, PubMed 16888032
  7. Gjeruldsen S, Loge JH, Myrvang B, Opjordsmoen S (2006)
    Drug addiction in hepatitis C patients leads to a lower quality of life
    Nord J Psychiatry, 60 (2), 157-61
    DOI 10.1080/08039480600583639, PubMed 16635936
  8. Hoel T, Wolter JM, Schuerman LM (2006)
    Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults
    Eur J Emerg Med, 13 (2), 67-71
    DOI 10.1097/01.mej.0000184993.51799.ad, PubMed 16525231
  9. Jensenius M, Fournier PE, Fladby T, Hellum KB, Hagen T, Priø T, Christiansen MS, Vene S, Raoult D, Myrvang B (2006)
    Sub-acute neuropathy in patients with African tick bite fever
    Scand J Infect Dis, 38 (2), 114-8
    DOI 10.1080/00365540500321579, PubMed 16449002
  10. Jensenius M, Montelius R, Berild D, Vene S (2006)
    Scrub typhus imported to Scandinavia
    Scand J Infect Dis, 38 (3), 200-2
    DOI 10.1080/00365540500277342, PubMed 16500780
  11. Kjetland EF, Mduluza T, Ndhlovu PD, Gomo E, Gwanzura L, Midzi N, Mason PR, Friis H, Gundersen SG (2006)
    Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel
    Trans R Soc Trop Med Hyg, 100 (8), 740-52
    DOI 10.1016/j.trstmh.2005.09.010, PubMed 16406034
  12. Kjetland EF, Ndhlovu PD, Gomo E, Mduluza T, Midzi N, Gwanzura L, Mason PR, Sandvik L, Friis H, Gundersen SG (2006)
    Association between genital schistosomiasis and HIV in rural Zimbabwean women
    AIDS, 20 (4), 593-600
    DOI 10.1097/01.aids.0000210614.45212.0a, PubMed 16470124
  13. Kran AM, Kvale D (2006)
    [Immunopathogenesis and therapeutic immunization in HIV-infection]
    Tidsskr Nor Laegeforen, 126 (23), 3112-6
    PubMed 17160117
  14. Kran AM, Sørensen B, Sommerfelt MA, Nyhus J, Baksaas I, Kvale D (2006)
    Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
    AIDS, 20 (4), 627-30
    DOI 10.1097/01.aids.0000210620.75707.ac, PubMed 16470131
  15. Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K (2006)
    Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
    AIDS, 20 (6), 813-20
    DOI 10.1097/01.aids.0000218544.54586.f1, PubMed 16549964
  16. Moghaddam A, Reinton N, Dalgard O (2006)
    A rapid real-time PCR assay for determination of hepatitis C virus genotypes 1, 2 and 3a
    J Viral Hepat, 13 (4), 222-9
    DOI 10.1111/j.1365-2893.2005.00678.x, PubMed 16611187
  17. Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN (2006)
    Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
    Antivir Ther, 11 (5), 601-8
    PubMed 16964828
  18. Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN (2006)
    Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients
    HIV Med, 7 (1), 53-8
    DOI 10.1111/j.1468-1293.2005.00336.x, PubMed 16313293
  19. Ndhlovu PD, Mduluza T, Kjetland EF, Midzi N, Nyanga L, Gundersen SG, Friis H, Gomo E (2006)
    Prevalence of urinary schistosomiasis and HIV in females living in a rural community of Zimbabwe: does age matter?
    Trans R Soc Trop Med Hyg, 101 (5), 433-8
    DOI 10.1016/j.trstmh.2006.08.008, PubMed 17064746
  20. Nygård K, Brantsaeter A, Feruglio S, Ravn J, Dotevall L, Hasle G, Myrvang B (2006)
    [Histoplasmosis among travellers to Central America]
    Tidsskr Nor Laegeforen, 126 (21), 2838-42
    PubMed 17086244
  21. Ormaasen V, Sandvik L, Rudberg N, Bruun JN (2006)
    Serum concentrations of protease inhibitors as predictors of HIV-related clinical events in patients on antiretroviral therapy
    Scand J Infect Dis, 38 (8), 650-3
    DOI 10.1080/00365540600616993, PubMed 16857610
  22. Skeie L, Maeland A (2006)
    Can efavirenz be taken in the morning?
    Scand J Infect Dis, 38 (11-12), 1089-91
    DOI 10.1080/00365540600794386, PubMed 17148083
  23. Storla DG, Rahim Z, Islam MA, Plettner S, Begum V, Mannsaaker T, Myrvang B, Bjune G, Dahle UR (2006)
    Heterogeneity of Mycobacterium tuberculosis isolates in Sunamganj District, Bangladesh
    Scand J Infect Dis, 38 (8), 593-6
    DOI 10.1080/00365540600606465, PubMed 16857601
  24. van de Vijver DA, Wensing AM, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2006)
    The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
    J Acquir Immune Defic Syndr, 41 (3), 352-60
    DOI 10.1097/01.qai.0000209899.05126.e4, PubMed 16540937
  25. von der Lippe B, Sandven P, Brubakk O (2006)
    Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases
    J Infect, 52 (2), 92-6
    DOI 10.1016/j.jinf.2005.04.007, PubMed 15907341

Publications 2005

  1. Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE (2005)
    Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
    Haematologica, 90 (1), 86-93
    PubMed 15642674
  2. Bergersen BM, Sandvik L, Ellingsen I, Bruun JN (2005)
    Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive
    HIV Med, 6 (4), 260-7
    DOI 10.1111/j.1468-1293.2005.00305.x, PubMed 16011531
  3. Bergersen BM, Tonstad S, Sandvik L, Bruun JN (2005)
    Low prevalence of high-density lipoprotein cholesterol level < 1 mmol/L in non-nucleoside reverse transcriptase inhibitor recipients
    Int J STD AIDS, 16 (5), 365-9
    DOI 10.1258/0956462053888808, PubMed 15949067
  4. Blystad H, Brantsaeter AB, Lovoll Ø (2005)
    Outbreak of community-acquired legionnaires disease in southeast Norway, May 2005
    Euro Surveill, 10 (5), E050526.1
    PubMed 16770016
  5. Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G (2005)
    Treatment outcome of new culture positive pulmonary tuberculosis in Norway
    BMC Public Health, 5, 14
    DOI 10.1186/1471-2458-5-14, PubMed 15698472
  6. Jensenius M, Flaegstad T, Stenstad T, Gjølberg T, Vlatkovic L, Schjøth-Iversen L, Berild D, Bordmann G, Myrvang B (2005)
    Fascioliasis imported to Norway
    Scand J Infect Dis, 37 (6-7), 534-7
    DOI 10.1080/00365540510034518, PubMed 16012024
  7. Jensenius M, Pretorius AM, Clarke F, Myrvang B (2005)
    Repellent efficacy of four commercial DEET lotions against Amblyomma hebraeum (Acari: Ixodidae), the principal vector of Rickettsia africae in southern Africa
    Trans R Soc Trop Med Hyg, 99 (9), 708-11
    DOI 10.1016/j.trstmh.2005.01.006, PubMed 15993907
  8. Kjetland EF, Gwanzura L, Ndhlovu PD, Mduluza T, Gomo E, Mason PR, Midzi N, Friis H, Gundersen SG (2005)
    Herpes simplex virus type 2 prevalence of epidemic proportions in rural Zimbabwean women: association with other sexually transmitted infections
    Arch Gynecol Obstet, 272 (1), 67-73
    DOI 10.1007/s00404-004-0689-8, PubMed 15647913
  9. Kjetland EF, Ndhlovu PD, Mduluza T, Gomo E, Gwanzura L, Mason PR, Kurewa EN, Midzi N, Friis H, Gundersen SG (2005)
    Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women
    Am J Trop Med Hyg, 72 (3), 311-9
    DOI 10.4269/ajtmh.2005.72.311, PubMed 15772328
  10. Kran AM, Sommerfelt MA, Sørensen B, Nyhus J, Baksaas I, Bruun JN, Kvale D (2005)
    Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
    Vaccine, 23 (31), 4011-5
    DOI 10.1016/j.vaccine.2005.03.010, PubMed 15963359
  11. Kvale D, Kran AM, Sommerfelt MA, Nyhus J, Baksaas I, Bruun JN, Sørensen B (2005)
    Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia
    AIDS, 19 (6), 563-7
    DOI 10.1097/01.aids.0000163932.76531.c6, PubMed 15802974
  12. Nygård K, Brantsaeter AB, Mehl R (2005)
    Disseminated and chronic Lyme borreliosis in Norway, 1995 - 2004
    Euro Surveill, 10 (10), 235-8
    PubMed 16282646
  13. Nyhus J, Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2005)
    Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
    Vaccine, 24 (10), 1543-50
    DOI 10.1016/j.vaccine.2005.10.012, PubMed 16289707
  14. Torfoss D, Sandven P (2005)
    Invasive fungal infections at The Norwegian Radium Hospital 1998-2003
    Scand J Infect Dis, 37 (8), 585-589
    DOI 10.1080/00365540510043301, PubMed 16138428
  15. Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2005)
    Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
    J Infect Dis, 192 (6), 958-66
    DOI 10.1086/432916, PubMed 16107947

Publications 2004

  1. Bergersen BM, Sandvik L, Bruun JN (2004)
    Body composition changes in 308 Norwegian HIV-positive patients
    Scand J Infect Dis, 36 (3), 186-91
    DOI 10.1080/00365540410019273, PubMed 15119363
  2. Bergersen BM, Sandvik L, Bruun JN, Tonstad S (2004)
    Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects
    Eur J Clin Microbiol Infect Dis, 23 (8), 625-30
    DOI 10.1007/s10096-004-1177-6, PubMed 15322938
  3. Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoërsdorff A, Blanco JR, Caruso G, Cinco M, Fournier PE, Francavilla E, Jensenius M, Kazar J, Laferl H, Lakos A, Lotric Furlan S, Maurin M, Oteo JA, Parola P, Perez-Eid C, Peter O, Postic D, Raoult D, Tellez A, Tselentis Y, Wilske B et al. (2004)
    Guidelines for the diagnosis of tick-borne bacterial diseases in Europe
    Clin Microbiol Infect, 10 (12), 1108-32
    DOI 10.1111/j.1469-0691.2004.01019.x, PubMed 15606643
  4. Baay MF, Kjetland EF, Ndhlovu PD, Deschoolmeester V, Mduluza T, Gomo E, Friis H, Midzi N, Gwanzura L, Mason PR, Vermorken JB, Gundersen SG (2004)
    Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution
    J Med Virol, 73 (3), 481-5
    DOI 10.1002/jmv.20115, PubMed 15170646
  5. Cook CC, Brekke K (2004)
    Productivity preservation through hydraulic propped fractures in the Eldfisk North Sea chalk field
    SPE Reserv. Eval. Eng., 7 (2), 105-114
  6. Dalgard O, Bjøro K, Hellum KB, Myrvang B, Ritland S, Skaug K, Raknerud N, Bell H (2004)
    Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study
    Hepatology, 40 (6), 1260-5
    DOI 10.1002/hep.20467, PubMed 15558712
  7. Jelinek T, Myrvang B (2004)
    Surveillance of imported infectious diseases in Europe: report from the 4th TropNetEurop workshop
    Acta Trop, 91 (1), 47-51
    DOI 10.1016/j.actatropica.2004.02.007, PubMed 15158688
  8. Jensenius M, Fournier PE, Vene S, Ringertz SH, Myrvang B, Raoult D (2004)
    Comparison of immunofluorescence, Western blotting, and cross-adsorption assays for diagnosis of African tick bite fever
    Clin Diagn Lab Immunol, 11 (4), 786-8
    DOI 10.1128/CDLI.11.4.786-788.2004, PubMed 15242958
  9. Kran AM, Sørensen B, Nyhus J, Sommerfelt MA, Baksaas I, Bruun JN, Kvale D (2004)
    HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
    AIDS, 18 (14), 1875-83
    DOI 10.1097/00002030-200409240-00003, PubMed 15353973
  10. Lugada ES, Mermin J, Asjo B, Kaharuza F, Downing R, Langeland N, Ormaasen V, Bruun J, Awor AC, Ulvestad E (2004)
    Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway
    Scand J Immunol, 59 (2), 203-8
    DOI 10.1111/j.0300-9475.2004.01376.x, PubMed 14871298
  11. Mühlberger N, Jelinek T, Gascon J, Probst M, Zoller T, Schunk M, Beran J, Gjørup I, Behrens RH, Clerinx J, Björkman A, McWhinney P, Matteelli A, Lopez-Velez R, Bisoffi Z, Hellgren U, Puente S, Schmid ML, Myrvang B, Holthoff-Stich ML, Laferl H, Hatz C, Kollaritsch H, Kapaun A, Knobloch J et al. (2004)
    Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop
    Malar J, 3, 5
    DOI 10.1186/1475-2875-3-5, PubMed 15003128
  12. Nilssen DE, Øktedalen O, Brandtzaeg P (2004)
    Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy
    Gut, 53 (4), 487-93
    DOI 10.1136/gut.2003.027854, PubMed 15016741
  13. Ormaasen V, Sandvik L, Asjø B, Holberg-Petersen M, Gaarder PI, Bruun JN (2004)
    An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy
    HIV Med, 5 (6), 400-6
    DOI 10.1111/j.1468-1293.2004.00244.x, PubMed 15544691
  14. Pretorius AM, Jensenius M, Birtles RJ (2004)
    Update on spotted fever group Rickettsiae in South Africa
    Vector Borne Zoonotic Dis, 4 (3), 249-60
    DOI 10.1089/vbz.2004.4.249, PubMed 15631070
  15. Rogne Gjeruldsen S, Myrvang B, Opjordsmoen S (2004)
    Criminality in drug addicts: a follow-up study over 25 years
    Eur Addict Res, 10 (2), 49-55
    DOI 10.1159/000076113, PubMed 15004447
  16. Rolain JM, Jensenius M, Raoult D (2004)
    Rickettsial infections--a threat to travellers?
    Curr Opin Infect Dis, 17 (5), 433-7
    DOI 10.1097/00001432-200410000-00008, PubMed 15353963
  17. Simonsen GS, Berdal JE, Sundsfjord A, Berild D (2004)
    [Simplified and not exact about antibiotics]
    Tidsskr Nor Laegeforen, 124 (18), 2397; author reply 2397-8
    PubMed 15467814
  18. Sivertsen EA, Torfoss D (2004)
    [Cryptococcal meningitis]
    Tidsskr Nor Laegeforen, 124 (1), 28-30
    PubMed 14716388

Publications 2003

  1. Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN (2003)
    Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients
    Eur J Clin Microbiol Infect Dis, 22 (12), 731-6
    DOI 10.1007/s10096-003-1034-z, PubMed 14610658
  2. Cozzi-Lepri A, Phillips AN, Miller V, Katlama C, Ledergerber B, Vella S, Weber J, Bruun JN, Kirk O, Clotet B, Lundgrens JD (2003)
    Changes in viral load in people with virological failure who remain on the same HAART regimen
    Antivir Ther, 8 (2), 127-36
    PubMed 12741625
  3. Gjeruldsen S, Myrvang B, Opjordsmoen S (2003)
    Risk factors for drug addiction and its outcome. A follow-up study over 25 years
    Nord J Psychiatry, 57 (5), 373-6
    DOI 10.1080/08039480310002714, PubMed 14522611
  4. Gjeruldsen SR, Myrvang B, Opjordsmoen S (2003)
    A 25-year follow-up study of drug addicts hospitalised for acute hepatitis: present and past morbidity
    Eur Addict Res, 9 (2), 80-6
    DOI 10.1159/000068805, PubMed 12644734
  5. Grobusch MP, Mühlberger N, Jelinek T, Bisoffi Z, Corachán M, Harms G, Matteelli A, Fry G, Hatz C, Gjørup I, Schmid ML, Knobloch J, Puente S, Bronner U, Kapaun A, Clerinx J, Nielsen LN, Fleischer K, Beran J, da Cunha S, Schulze M, Myrvang B, Hellgren U (2003)
    Imported schistosomiasis in Europe: sentinel surveillance data from TropNetEurop
    J Travel Med, 10 (3), 164-9
    DOI 10.2310/7060.2003.35759, PubMed 12757691
  6. Jensenius M, Fournier PE, Hellum KB, Wesslén L, Caruso G, Priø T, Løhne K, Vene S, Raoult D, Myrvang B (2003)
    Sequential changes in hematologic and biochemical parameters in African tick bite fever
    Clin Microbiol Infect, 9 (7), 678-83
    DOI 10.1046/j.1469-0691.2003.00713.x, PubMed 12925109
  7. Jensenius M, Fournier PE, Kelly P, Myrvang B, Raoult D (2003)
    African tick bite fever
    Lancet Infect Dis, 3 (9), 557-64
    DOI 10.1016/S1473-3099(03)00739-4, PubMed 12954562
  8. Jensenius M, Fournier PE, Vene S, Hoel T, Hasle G, Henriksen AZ, Hellum KB, Raoult D, Myrvang B, Norwegian African Tick Bite Fever Study Group (2003)
    African tick bite fever in travelers to rural sub-Equatorial Africa
    Clin Infect Dis, 36 (11), 1411-7
    DOI 10.1086/375083, PubMed 12766836
  9. Jensenius M, Ueland T, Fournier PE, Brosstad F, Stylianou E, Vene S, Myrvang B, Raoult D, Aukrust P (2003)
    Systemic inflammatory responses in African tick-bite fever
    J Infect Dis, 187 (8), 1332-6
    DOI 10.1086/368415, PubMed 12696016
  10. Maeland A, Ronnestad I, Waagbo R (2003)
    Folate in eggs and developing larvae of Atlantic halibut, Hippoglossus hippoglossus L.
    Aquac. Nutr., 9 (3), 185-188
  11. Midzi N, Ndhlovu PD, Nyanga L, Kjetland EF, Reimert CM, Vennervald BJ, Gomo E, Mudenge G, Friis H, Gundersen SG, Mduluza T (2003)
    Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area
    Parasite Immunol, 25 (11-12), 581-8
    DOI 10.1111/j.0141-9838.2004.00670.x, PubMed 15053779
  12. Mühlberger N, Jelinek T, Behrens RH, Gjørup I, Coulaud JP, Clerinx J, Puente S, Burchard G, Gascon J, Grobusch MP, Weitzel T, Zoller T, Kollaritsch H, Beran J, Iversen J, Hatz C, Schmid ML, Björkman A, Fleischer K, Bisoffi Z, Guggemos W, Knobloch J, Matteelli A, Schulze MH, Laferl H et al. (2003)
    Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data
    Clin Infect Dis, 36 (8), 990-5
    DOI 10.1086/374224, PubMed 12684911
  13. Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI (2003)
    Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection
    Scand J Infect Dis, 35 (6-7), 383-8
    DOI 10.1080/00365540310009716, PubMed 12953949
  14. Pretorius AM, Jensenius M, Clarke F, Ringertz SH (2003)
    Repellent efficacy of DEET and KBR 3023 against Amblyomma hebraeum (Acari: Ixodidae)
    J Med Entomol, 40 (2), 245-8
    DOI 10.1603/0022-2585-40.2.245, PubMed 12693855

Publications 2002

  1. Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O et al. (2002)
    Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks
    Int J Epidemiol, 31 (5), 951-8
    DOI 10.1093/ije/31.5.951, PubMed 12435766
  2. Bell H, Dalgard O, Bjøro K, Hellum KB, Myrvang B (2002)
    [Treatment of chronic hepatitis C]
    Tidsskr Nor Laegeforen, 122 (9), 926-8
    PubMed 12082838
  3. Berild D, Lindbaek M (2002)
    [Are too many antibiotics prescribed to Norwegian children?]
    Tidsskr Nor Laegeforen, 122 (28), 2690
    PubMed 12523084
  4. Berild D, Ringertz SH, Aabyholm G, Lelek M, Fosse BH (2002)
    Impact of an antibiotic policy on antibiotic use in a paediatric department. Individual based follow-up shows that antibiotics were chosen according to diagnoses and bacterial findings
    Int. J. Antimicrob. Agents, 20 (5), PII S0924-8579(02)00203-0-338
  5. Bjøro K, Bell H, Hellum KB, Skaug K, Raknerud N, Sandvei P, Døskeland B, Maeland A, Lund-Tønnesen S, Myrvang B (2002)
    Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study
    Scand J Gastroenterol, 37 (2), 226-32
    DOI 10.1080/003655202753416920, PubMed 11843062
  6. Bjøro K, Bell H, Myrvang B, Skaug K, Raknerud N, Sandvei P, Størseth S, Ritland S, Lund-Tønnesen S, Bucher A, Hellum KB (2002)
    Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study
    Scand J Gastroenterol, 37 (3), 344-9
    DOI 10.1080/003655202317284264, PubMed 11916198
  7. Brantsaeter AB, Liestøl K, Goplen AK, Dunlop O, Bruun JN (2002)
    CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo
    Scand J Infect Dis, 34 (1), 50-5
    DOI 10.1080/00365540110076976, PubMed 11874165
  8. Bruun JN, Maeland A (2002)
    [Mother-to-child transmission of HIV]
    Tidsskr Nor Laegeforen, 122 (11), 1143; author reply 1143
    PubMed 12043061
  9. Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bell H (2002)
    Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy
    J Intern Med, 251 (5), 400-6
    DOI 10.1046/j.1365-2796.2002.00974.x, PubMed 11982739
  10. Dalgard O, Bjøro K, Hellum K, Myrvang B, Skaug K, Gutigard B, Bell H, Construct Group (2002)
    Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up
    Eur Addict Res, 8 (1), 45-9
    DOI 10.1159/000049487, PubMed 11818693
  11. Distante S, Bjøro K, Hellum KB, Myrvang B, Berg JP, Skaug K, Raknerud N, Bell H (2002)
    Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection
    Liver, 22 (3), 269-75
    DOI 10.1046/j.0106-9543.2002.01672.x, PubMed 12100578
  12. Dunlop O, Bjørklund R, Bruun JN, Evensen R, Goplen AK, Liestøl K, Sannes M, Maehlen J, Myrvang B (2002)
    Early psychomotor slowing predicts the development of HIV dementia and autopsy-verified HIV encephalitis
    Acta Neurol Scand, 105 (4), 270-5
    DOI 10.1034/j.1600-0404.2002.9o188.x, PubMed 12004769
  13. Fournier PE, Jensenius M, Laferl H, Vene S, Raoult D (2002)
    Kinetics of antibody responses in Rickettsia africae and Rickettsia conorii infections
    Clin Diagn Lab Immunol, 9 (2), 324-8
    DOI 10.1128/cdli.9.2.324-328.2002, PubMed 11874871
  14. Gjeruldsen S, Myrvang B (2002)
    Hepatitis B virus infection in drug addicts: no acute fatalities, no chronicity and could have benefits
    APMIS, 110 (9), 620-4
    DOI 10.1034/j.1600-0463.2002.1100904.x, PubMed 12529014
  15. Holm AM, Berild D, Ringertz SH, Håheim LL, Høiby EA (2002)
    Occurrence and clinical presentation of systemic pneumococcal infections in an unselected population in Oslo, Norway, between 1993 and 1997
    Eur J Clin Microbiol Infect Dis, 21 (6), 465-7
    DOI 10.1007/s10096-002-0751-z, PubMed 12111604
  16. Jelinek T, Mühlberger N, Harms G, Corachán M, Grobusch MP, Knobloch J, Bronner U, Laferl H, Kapaun A, Bisoffi Z, Clerinx J, Puente S, Fry G, Schulze M, Hellgren U, Gjørup I, Chalupa P, Hatz C, Matteelli A, Schmid M, Nielsen LN, da Cunha S, Atouguia J, Myrvang B, Fleischer K et al. (2002)
    Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop
    Clin Infect Dis, 35 (9), 1047-52
    DOI 10.1086/342906, PubMed 12384837
  17. Jensenius M, Hoel T, Raoult D, Fournier PE, Kjelshus H, Bruu AL, Myrvang B (2002)
    Seroepidemiology of Rickettsia africae infection in Norwegian travellers to rural Africa
    Scand J Infect Dis, 34 (2), 93-6
    DOI 10.1080/00365540110077029, PubMed 11928860
  18. Leegaard TM, Caugant DA, Frøholm LO, Høiby EA, Rønning EJ, Sandven P, Bruun JN (2002)
    Do HIV-seropositive patients become colonised with drug-resistant microorganisms?
    Eur J Clin Microbiol Infect Dis, 21 (12), 856-63
    DOI 10.1007/s10096-002-0827-9, PubMed 12525920
  19. Miller V, Phillips AN, Clotet B, Mocroft A, Ledergerber B, Kirk O, Ormaasen V, Gargalianos-Kakolyris P, Vella S, Lundgren JD (2002)
    Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts
    J Infect Dis, 186 (2), 189-97
    DOI 10.1086/341466, PubMed 12134254
  20. Myrvang B, von der Lippe B (2002)
    [African trypanosomiasis--a rare imported disease]
    Tidsskr Nor Laegeforen, 122 (1), 33-4
    PubMed 11851292
  21. Mørch K, Feruglio SL, Ormaasen V, Bruun JN (2002)
    [Severe falciparum malaria treated with exchange transfusion]
    Tidsskr Nor Laegeforen, 122 (10), 999-1001
    PubMed 12082710
  22. Maagaard A, Oktedalen O (2002)
    Psoas abscess diagnosed at a Northern university hospital
    Scand J Infect Dis, 34 (11), 848-51
    DOI 10.1080/0036554021000026940, PubMed 12578159
  23. Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI (2002)
    A search for optimal criteria in initiating antiretroviral therapy in chronic human immunodeficiency virus infection focusing on CD4 count and HIV RNA
    Scand J Infect Dis, 34 (12), 910-7
    DOI 10.1080/0036554021000026957, PubMed 12587624
  24. Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holter E, Degré M, Nordal KP (2002)
    Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
    Clin Microbiol Infect, 8 (7), 431-4
    DOI 10.1046/j.1469-0691.2002.00449.x, PubMed 12199854
  25. Røttingen JA, Feruglio SL, Aasland OG, Fugelli P (2002)
    [Local and global environmental medicine--assessment by Norwegian physicians]
    Tidsskr Nor Laegeforen, 122 (13), 1285-9
    PubMed 12098923
  26. Småbrekke L, Berild D, Giaever A, Myrbakk T, Fuskevåg A, Ericson JU, Flaegstad T, Olsvik O, Ringertz SH (2002)
    Educational intervention for parents and healthcare providers leads to reduced antibiotic use in acute otitis media
    Scand J Infect Dis, 34 (9), 657-9
    DOI 10.1080/00365540210147651, PubMed 12374355
  27. Strand EA, Strand ØA, Hellum KB, Smith-Erichsen N, Myrvang B (2002)
    [A young, stuporous and afebrile man with icterus and nosebleed]
    Tidsskr Nor Laegeforen, 122 (6), 619-23
    PubMed 11998715
  28. Tobiassen T, Berild D, Hjortdahl P (2002)
    [Use of systemic antibiotics in a Norwegian nursing home]
    Tidsskr Nor Laegeforen, 122 (24), 2376-8
    PubMed 12448254

Publications 2001

  1. Bruun JN (2001)
    [Import of resistant bacteria]
    Tidsskr Nor Laegeforen, 121 (2), 156
    PubMed 11475187
  2. Fylkesnes SI, Jensenius M, Norheim I (2001)
    [A woman with Addison's disease and a bump on the neck]
    Tidsskr Nor Laegeforen, 121 (10), 1259, 1261
    PubMed 11402756
  3. Gjeruldsen S, Abdelnoor M, Opjordsmoen S, Myrvang B (2001)
    Death rates and causes of death in cohorts of serum hepatitis patients followed up for more than 20 years
    Epidemiol Infect, 126 (1), 89-96
    DOI 10.1017/s0950268801005064, PubMed 11293686
  4. Goplen AK, Liestøl K, Dunlop O, Bruun JN, Maehlen J (2001)
    Dementia in AIDS patients in Oslo; the role of HIV encephalitis and CMV encephalitis
    Scand J Infect Dis, 33 (10), 755-8
    DOI 10.1080/003655401317074572, PubMed 11728043
  5. Haug JB (2001)
    [Dangerous bacterial conditions]
    Tidsskr Nor Laegeforen, 121 (28), 3262
    PubMed 11826454
  6. Kirk O, Mocroft A, Pradier C, Bruun JN, Hemmer R, Clotet B, Miller V, Viard JP, Phillips AN, Lundgren JD, EuroSIDA Study Group (2001)
    Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir
    AIDS, 15 (8), 999-1008
    DOI 10.1097/00002030-200105250-00008, PubMed 11399982
  7. Oktedalen O, Solberg EE, Haugen AH, Opstad PK (2001)
    The influence of physical and mental training on plasma beta-endorphin level and pain perception after intensive physical exercise
    Stress Health, 17 (2), 121-127
  8. Ormaasen V, Brantsaeter AB, Moen EW (2001)
    [Tick-borne encephalitis in Norway]
    Tidsskr Nor Laegeforen, 121 (7), 807-9
    PubMed 11301704
  9. Ormaasen V, Bruun JN (2001)
    [Antiviral therapy of HIV infection in adults]
    Tidsskr Nor Laegeforen, 121 (29), 3414-20
    PubMed 11826789
  10. Ormaasen V, Maeland A (2001)
    [Tuberculosis among HIV-infected persons in Norway]
    Tidsskr Nor Laegeforen, 121 (29), 3425-30
    PubMed 11826791
  11. Os I, Ström EH, Stenehjem A, Gudmundsdottir H, Langberg H, Draganov B, Godøy J, Dunlop O, von der Lippe B (2001)
    Varicella infection in a renal transplant recipient associated with abdominal pain, hepatitis, and glomerulonephritis
    Scand J Urol Nephrol, 35 (4), 330-3
    DOI 10.1080/003655901750425945, PubMed 11676362
  12. Raoult D, Fournier PE, Fenollar F, Jensenius M, Prioe T, de Pina JJ, Caruso G, Jones N, Laferl H, Rosenblatt JE, Marrie TJ (2001)
    Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa
    N Engl J Med, 344 (20), 1504-10
    DOI 10.1056/NEJM200105173442003, PubMed 11357153
  13. Svendsen J, Ormaasen V, von der Lippe E, Jacobsen D (2001)
    [Two cases of pneumococcal pericarditis]
    Tidsskr Nor Laegeforen, 121 (15), 1801-3
    PubMed 11464685
  14. Viard JP, Mocroft A, Chiesi A, Kirk O, Røge B, Panos G, Vetter N, Bruun JN, Johnson M, Lundgren JD, EuroSIDA Study Group (2001)
    Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study
    J Infect Dis, 183 (8), 1290-4
    DOI 10.1086/319678, PubMed 11262215

Publications 2000

  1. Brubakk O, Myrvang B (2000)
    [Non-practical guidelines?]
    Tidsskr Nor Laegeforen, 120 (26), 3196
    PubMed 11109372
  2. Bøyum A, Tennfjord VA, Gran C, Løvhaug D, Oktedalen O, Brandtzaeg P (2000)
    Bioactive cytidine deaminase, an inhibitor of granulocyte-macrophage colony-forming cells, is massively released in fulminant meningococcal sepsis
    J Infect Dis, 182 (6), 1784-7
    DOI 10.1086/317596, PubMed 11069255
  3. Dyrhol-Riise AM, Brantsaeter AB, Dunlop O, Baklien K, Skar AG, Asjö B, Bruun JN, Røsok BI (2000)
    Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals
    Scand J Immunol, 51 (2), 195-201
    DOI 10.1046/j.1365-3083.2000.00659.x, PubMed 10652164
  4. Jensenius M, Høiby EA, Berild D, Stiris M, Ringertz SH (2000)
    Difficulties in diagnosing Brucella spondylitis
    Scand J Infect Dis, 32 (4), 425-6
    DOI 10.1080/003655400750045051, PubMed 10959656
  5. Jonassen TO, Grinde B, Asjö B, Hasle G, Hungnes O (2000)
    Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases
    AIDS Res Hum Retroviruses, 16 (1), 49-58
    DOI 10.1089/088922200309593, PubMed 10628816
  6. Liestøl K, Kvittingen EA, Rootwelt H, Dunlop O, Goplen AK, Pedersen JC, Brorson SH, Børresen-Dale AL, Myrvang B, Maehlen J (2000)
    Association between apolipoprotein E genotypes and cancer risk in patients with acquired immunodeficiency syndrome
    Cancer Detect Prev, 24 (5), 496-9
    PubMed 11129992
  7. Løvstad RZ, Berntsen AG, Berild D, Stiris M (2000)
    [Intraspinal infections in patients treated with epidural analgesia]
    Tidsskr Nor Laegeforen, 120 (20), 2403-6
    PubMed 11475225
  8. Maeland A, Ronnestad I, Fyhn HJ, Berg L, Waagbo R (2000)
    Water-soluble vitamins in natural plankton (copepods) during two consecutive spring blooms compared to vitamins in Artemia franciscana nauplii and metanauplii
    Mar. Biol., 136 (5), 765-772
  9. Mellgren A, Norkrans G, Hagberg L, Dunlop O, Wejstål R, Gisslén M (2000)
    Slowed reaction time in HIV-1-infected patients without AIDS
    Acta Neurol Scand, 102 (3), 169-74
    DOI 10.1034/j.1600-0404.2000.102003169.x, PubMed 10987376
  10. Mørk C, Kalgaard OM, Myrvang B, Kvernebo K (2000)
    Erythromelalgia in a patient with AIDS
    J Eur Acad Dermatol Venereol, 14 (6), 498-500
    DOI 10.1046/j.1468-3083.2000.00145.x, PubMed 11444274
  11. Olsen AI, Maeland A, Waagbo R, Olsen Y (2000)
    Effect of algal addition on stability of fatty acids and some water-soluble vitamins in juvenile Artemia franciscana
    Aquac. Nutr., 6 (4), 263-273
  12. Ringertz SH, Høiby EA, Jensenius M, Maehlen J, Caugant DA, Myklebust A, Fossum K (2000)
    Injectional anthrax in a heroin skin-popper
    Lancet, 356 (9241), 1574-5
    DOI 10.1016/s0140-6736(00)03133-0, PubMed 11075776
  13. Rønning EJ, Myrvang B, Jensenius M (2000)
    [Falciparum malaria in Oslo and Akerhus]
    Tidsskr Nor Laegeforen, 120 (14), 1658-60
    PubMed 10901077
  14. Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degré M, Rollag H (2000)
    Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
    Scand J Immunol, 51 (4), 354-60
    DOI 10.1046/j.1365-3083.2000.00676.x, PubMed 10736107
  15. Strand OA, Leone A, Giercksky KE, Kirkebøen KA (2000)
    Nitric oxide indices in human septic shock
    Crit Care Med, 28 (8), 2779-85
    DOI 10.1097/00003246-200008000-00017, PubMed 10966250
 
Page visits: 4835